Updated on 2026/03/06

写真a

 
TAGAMI Mizuki
 
Organization
Graduate School of Medicine Department of Clinical Medical Science Lecturer
School of Medicine Department of Medical Science
Title
Lecturer
Affiliation
Institute of Medcine
Profile
1997年 兵庫県立神戸高等学校卒業 2004年 藤田保健衛生大学医学部卒業 2004年 神戸労災病院初期臨床研修医 2005年 神戸大学医学部附属病院初期臨床研修医 2006年 神戸大学医学部附属病院眼科専攻医 2010年 神戸大学医学部眼科特定助教 2011年 神戸大学大学院外科系講座眼科学修了(医学博士) 2011年 ジョンズホプキンス大学ウィルマー眼研究所 2012年 三菱神戸病院医員 2013年 神戸海星病院眼科医長 2018年 神戸海星病院眼科部長
Affiliation campus
Abeno Campus

Position

  • Graduate School of Medicine Department of Clinical Medical Science 

    Lecturer  2022.04 - Now

  • School of Medicine Department of Medical Science 

    Lecturer  2022.04 - Now

Degree

  • 医学博士 ( Kobe University )

Research Areas

  • Life Science / Ophthalmology

  • Life Science / Ophthalmology  / vitreoretina ocular oncology ocular inflamation

Research Interests

  • 眼炎症

  • 眼腫瘍

  • 網膜硝子体手術

Research subject summary

  • Ocular oncology, ocular inflammation, vitreoretinal surgery

Professional Memberships

  • JAPANESE OPHTHALMOLOGICAL SOCIETY

  • 日本眼腫瘍学会

  • JAPANESE RETINA AND VITREOUS SOCIETY

Job Career (off-campus)

  • Osaka City University

Education

  • Fujita Health University     Graduated/Completed

    1998.04 - 2004.03

  • Kobe University   Doctor's Course   Graduated/Completed

Papers

  • Applications of New Generation Sequencing (NGS) in Ocular Oncology.

    Mizuki Tagami, Shigeru Honda

    International ophthalmology clinics   65 ( 4 )   1 - 4   2025.10( ISSN:0020-8167

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Next-generation sequencing (NGS) has revolutionized cancer genomics, offering unparalleled insights into the molecular landscape of various malignancies, including ocular cancers. This review explores the role of NGS in ocular oncology, highlighting its impact on understanding genetic alterations, identifying biomarkers, and advancing personalized treatment approaches. Key applications in uveal melanoma, retinoblastoma, and other ocular tumors, including ocular adnexa lymphoma and IgG4-related ophthalmic disease are discussed, along with the challenges and future directions in the field. As sequencing technologies continue to evolve, integrating NGS into clinical practice promises to enhance early diagnosis, risk assessment, and therapeutic strategies in ocular oncology.

    DOI: 10.1097/IIO.0000000000000584

    PubMed

  • 症例報告1 テプロツムマブ投与後に高血糖をきたした症例

    木下 舜一, 越智 章展, 田上 瑞記, 宮本 祥子, 三木 祐哉, 角谷 佳則, 永田 友貴, 藏城 雅文, 今西 康雄, 森岡 与明, 繪本 正憲

    糖尿病合併症   39 ( Suppl.1 )   218 - 218   2025.10

  • 綜説 眼球突出の鑑別──眼球突出に対する体系的な診断アプローチ:臨床所見,画像診断,人種差の考慮

    田上 瑞記

    眼科   67 ( 9 )   809 - 813   2025.09( ISSN:00164488

  • Gene expression cluster differences and molecular correlation with the STING pathway in orbital MALT lymphoma and orbital IgG4-related eye disease.

    Mizuki Tagami, Keishiro Isayama, Mizuho Nishio, Atsuko Yoshikawa, Norihiko Misawa, Atsushi Sakai, Yusuke Haruna, Mami Tomita, Yoichi Mizukami, Atsushi Azumi, Shigeru Honda

    Discover oncology   16 ( 1 )   1466 - 1466   2025.08

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    PURPOSE: Mucosa-associated lymphoid tissue (MALT) lymphoma in the orbital region and IgG4-related ophthalmic disease (IgG4-ROD) account for the majority of mass lesions in the orbital region. These diseases may show similar shadows on radiologic images, and many cases are difficult to differentiate clinically. Using histology, we investigated the gene expression clusters (RNA-seq) and molecular differences responsible for these two diseases. DESIGN: Retrospective cohort study. SUBJECTS: Patients diagnosed with orbital MALT and IgG4-ROD who underwent surgical treatment at Osaka Metropolitan University or Kobe Kaisei Hospital, Japan, were included in the study. METHODS: Fresh tissues extracted from 20 cases of MALT lymphoma and IgG4-ROD histopathologically diagnosed were subjected to next-generation sequencing analysis, and a sequence library was generated. Next-generation sequencing analysis was performed to compare gene expression between the two groups, and principal component and cluster hierarchy analyses were performed. Genes exhibiting significant changes in expression were examined individually after pathway analysis; immunohistochemical staining was performed to determine the intensity and staining morphology of components of significantly altered pathways. MAIN OUTCOME MEASURES: Gene cluster differences between orbital MALT lymphoma and IgG4-ROD. RESULTS: In principal component analysis, orbital MALT lymphoma and IgG4-ROD clustered in component 2. Clear cluster differences were observed, except for one case that appeared to be IgG4-producing MALT lymphoma. This apparent case of IgG4-producing MALT lymphoma clustered just between the IgG4-ROD and MALT lymphoma clusters. Analysis of upregulated genes between IgG4-ROD and MALT lymphoma identified 582 candidate genes (P < 0.01). Pathway analysis of MALT lymphoma suggested that the STING pathway was activated. Downstream pathway analysis identified eight significant gene expression changes (P < 0.05). STING immunohistochemical analysis indicated a quantitative difference in staining pattern between IgG4-ROD and MALT lymphoma (P < 0.01). STING-positive staining within cells was significantly greater in MALT than the Golgi complex near the nucleus. CONCLUSIONS: Orbital MALT lymphoma and IgG4-ROD can be differentiated by two gene expression clusters. The STING pathway may play a more important role in orbital MALT lymphoma than orbital IgG4-ROD.

    DOI: 10.1007/s12672-025-03239-y

    PubMed

  • Different distribution and density of myofibroblasts in idiopathic epiretinal membrane and epiretinal membrane in proliferative diabetic retinopathy.

    Luu Viet Tien, Manabu Yamamoto, Mizuki Tagami, Shigeru Honda

    Scientific reports   15 ( 1 )   22767 - 22767   2025.07

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Myofibroblasts were recently identified as the most critical cells responsible for epiretinal membrane contraction, however the myofibroblast number in different types of membranes may differ substantially. In this retrospective study, we compare myofibroblast distribution and density in idiopathic epiretinal membranes (iERMs) and epiretinal membranes (ERMs) in proliferative diabetic retinopathy (PDR). Samples (n = 42) from iERM and from thin ERM, ERM, and epiretinal fibrovascular membrane (FVM) in PDR (thin ERM/PDR, ERM/PDR, and FVM/PDR, respectively) were collected via a standard 27-gauge vitrectomy. They were analyzed using flat-mount immunohistochemical staining with α-smooth muscle actin. Cell densities (in cells/mm2) for iERM, thin ERM/PDR, ERM/PDR, and FVM/PDR were 339.00 ± 256.76, 12.39 ± 7.46, 114.22 ± 40.51, and 844.15 ± 323.21, respectively, and significantly different (P < 0.001). Myofibroblast densities (in cells/mm2) in these groups were 39.48 ± 46.51, 0.65 ± 0.95, 9.22 ± 12.08, and 303.43 ± 57.21, respectively, and significantly different (P < 0.001). Myofibroblast density in iERM was higher than that of thin ERM/PDR (P < 0.001), higher but not significantly different from ERM/PDR (P = 0.077), and lower than that of FVM/PDR (P < 0.001). The myofibroblasts/total cell ratios in these groups were 12.66% ± 12.38%, 5.89% ± 9.78%, 9.55% ± 10.86%, and 40.35% ± 14.37%, respectively, and significantly different (P < 0.001). Myofibroblast density was strongly correlated with cell density and the myofibroblast/total cell ratio (P < 0.001).

    DOI: 10.1038/s41598-025-05199-3

    PubMed

  • 眼トキソプラズマ症による黄斑部網膜動脈閉塞の1例

    木成 玄, 田上 瑞記, 坂井 淳, 三澤 宣彦, 冨田 真未, 春名 優甫, 本田 茂

    眼科臨床紀要   18 ( 4 )   273 - 273   2025.04( ISSN:1882-5176

  • 脈絡膜mucosa-associated lymphoid tissue(MALT)リンパ腫に対しリツキシマブ単剤投与で視力改善と長期緩解を得た1例

    三澤 宣彦, 田上 瑞記, 春名 優甫, 冨田 真未, 坂井 淳, 田中 さやか, 康 秀男, 本田 茂

    日本眼科学会雑誌   129 ( 4 )   467 - 476   2025.04( ISSN:0029-0203

     More details

    背景:眼内外病変を伴う脈絡膜mucosa-associated lymphoid tissue(MALT)リンパ腫に対して,眼外病変の生検による診断ののち,リツキシマブ単剤投与を行い,視力改善と長期緩解を得た症例を報告する.症例:77歳,男性.X年1月より右眼の霧視を自覚し前医を受診した.矯正視力は右0.2,左1.0であった.右眼耳側結膜に充血病巣を認め,前医にて加療されるも改善なく,次第に漿液性網膜剥離を認めた.頭部磁気共鳴画像法(MRI)にて眼内から眼外まで連続する腫瘍を指摘され,X年2月に当院紹介となった.当院受診時の右眼の矯正視力は0.5であり,右眼耳側結膜にはピンク色で2cm程度の結膜下病変を,眼底には漿液性網膜剥離を伴う広範な脈絡膜肥厚を認めた.結膜下の病変に対して生検を施行し,脈絡膜MALTリンパ腫と診断した.ポジトロン断層法-コンピュータ断層撮影(PET-CT)ではリンパ節転移や遠隔転移は認めなかった.リツキシマブの単剤投与を開始し,開始後2ヵ月ほどで眼内外脈絡膜腫瘍は完全に消失した.加療開始後2年での右眼の矯正視力は1.2と改善し,現在も経過観察中である.結論:リツキシマブ単剤投与での報告は少数であるが,本症例では漿液性網膜剥離の改善と矯正視力の改善を得ることができた.リツキシマブ単剤投与のみでも長期に寛解状態を維持することができ,脈絡膜MALTリンパ腫の治療においてリツキシマブ単剤による加療も今後選択肢となり得ることが示された.(著者抄録)

  • Correlation Between Changes in Extraocular Muscles and Intraocular Pressure Following Anti-Inflammatory Therapy in Active Thyroid Eye Disease.

    Yusuke Haruna, Mizuki Tagami, Mami Tomita, Atsushi Sakai, Norihiko Misawa, Kazuo Asano, Yusuke Murai, Atsuko Yoshikawa, Atsushi Azumi, Shigeru Honda

    Journal of clinical medicine   14 ( 5 )   2025.02( ISSN:2077-0383

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Objectives: We investigate the correlation between functional and morphological changes in extraocular muscles (EOMs) and intraocular pressure (IOP) changes before and after thyroid eye disease (TED) treatment. Methods: A multicenter study with a retrospective chart review was conducted. Patients with active TED receiving corticosteroid therapy without glaucoma eye drops between 2014 and 2023 were reviewed. Various parameters were measured by magnetic resonance imaging. The primary outcome measure was the correlation between changes in the IOP and the cross-sectional area (CSA) of the EOMs before and after treatment. Secondary outcome measures were comparisons of IOP, the signal intensity ratio (SIR) of the EOMs and orbital fatty tissue (OFT), and the CSA of the EOMs before and after treatment. Results: The IOP in 99 eyes in 51 patients significantly decreased from 18 ± 3.4 mmHg to 15.5 ± 2.9 mmHg before and after treatment (p < 0.01)). The CSA and SIR of all EOMs and OFT significantly decreased after treatment (p < 0.05). Factors that had a significant positive correlation with the IOP change rate before and after treatment were the CSA change rate of the inferior rectus muscle (IRM) before and after treatment (Spearman's correlation coefficient, R2 = 0.24, p < 0.05) and the CSA change rate of the total EOMs before and after treatment (Spearman's correlation coefficient, R2 = 0.22, p < 0.05). Conclusions: In TED patients, IOP decreased with anti-inflammatory treatment alone. The most significant parameter that correlated with the decrease in IOP was the CSA change rate of the IRM.

    DOI: 10.3390/jcm14051480

    PubMed

  • ディープラーニングを用いた甲状腺眼症の評価プログラム開発:Mambaの有効性の検証

    黑﨑 涼, 西尾 瑞穂, 春名 優甫, 木成 玄, 冨田 真未, 田上 瑞記, 本田 茂, 村垣 善浩

    生体医工学   Annual63 ( Abstract )   215_1 - 215_1   2025( ISSN:1347443X ( eISSN:18814379

     More details

    <p>(はじめに)甲状腺眼症における治療効果の評価では、MRI画像上での外眼筋と他の臓器の信号強度比が指標の一つとされる。算出には医師がSTIR法の冠状断からROIを指定する必要がある。一般にSTIR法のMRIはCTなどと比べてコントラストが高いが、甲状腺眼症の活動性が低い時には外眼筋と周囲組織とのコントラストが低く、この場合には外眼筋セグメンテーションは難しい。我々が知る限り先行研究でSTIR法での外眼筋セグメンテーションは確認されていない。(目的)本研究は甲状腺眼症の治療効果判定の自動化を目的としている。我々はディープラーニングのロバスト性に注目し、甲状腺眼症患者の外眼筋抽出に有効か評価する。加えて、新たなモデルMambaの有効性も評価する。(方法)甲状腺眼症患者52例(1225枚)を対象とし、データセットを構築した(上直筋、下直筋、内直筋、外直筋の全4クラス)。7種類の3Dセグメンテーションモデルを5-foldクロスバリデーションで学習させた。(結果)各モデルのDice係数の平均値は、0.7961(U-Mamba Enc)、0.7960(U-Mamba Bot)、0.7957(nnU-Net ResEnc L)、0.7788(SegResNet)、0.7733(V-Net)、0.7442(UNETR)、0.7087(SwinUNETR)となり、U-Mamba Encが最も高い結果となった。</p>

    DOI: 10.11239/jsmbe.annual63.215_1

    CiNii Research

  • A Case of Branch Retinal Artery Occlusion With Concomitant Intraocular and Extraocular Toxoplasmosis Lesions in a Japanese Man.

    Gen Kinari, Mizuki Tagami, Mami Tomita, Norihiko Misawa, Atsushi Sakai, Yusuke Haruna, Taro Shimono, Shigeru Honda

    Case reports in ophthalmological medicine   2025   6654053 - 6654053   2025( ISSN:2090-6722

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Purpose: The purpose of the study is to report a case of ocular toxoplasmosis with branch retinal artery occlusion (BRAO). Case: The patient was a 36-year-old man from Okinawa, Japan, who was generally healthy and had no medical history. He was referred to our hospital with a complaint of sudden loss of vision in the left eye. Best corrected visual acuity was 0.1 in the left eye at the initial examination, and intraocular pressure was 21 mmHg. Anterior segment slit-lamp examination showed a few cells of the anterior segment and anterior vitreous. Fundus examination of the left eye showed retinal vasculitis of the middle and large retinal vessels with occlusion of retinal arterioles in the macular area and edema in all layers of the retina, with dense posterior vitreous cells and flare. Magnetic resonance imaging (MRI) showed a mass shadow at the posterior part of the left eyeball near the macula in the orbit. On laboratory examination, toxoplasma serum IgM and IgG were positive. Based on these results, he was diagnosed with BRAO with concomitant intraocular and extraocular toxoplasmosis. He was then treated with clindamycin, sulfamethoxazole-trimethoprim, and steroids. The inflammation disappeared quickly, and visual acuity improved to 0.6. The inflammation had not flared up even 3 months after the initial visit with decreasing serum toxoplasma serum IgG levels, and the posterior eyeball shadow on the MRI disappeared. Conclusion: A case of BRAO with uveitis with concomitant intraocular and extraocular toxoplasmosis lesions was presented. In cases of unilateral retinal vasculitis with orbital lesions, concomitant intraocular and extraocular toxoplasmosis should also be considered.

    DOI: 10.1155/crop/6654053

    PubMed

  • Correlation Between Postoperative Vitreous Hemorrhage and Preoperative Evaluation of Optical Coherence Tomography Angiography in Proliferative Diabetic Retinopathy Surgery.

    Yusuke Haruna, Mizuki Tagami, Gen Kinari, Atsushi Sakai, Shigeru Honda

    Journal of ophthalmology   2025 ( 1 )   7839246 - 7839246   2025( ISSN:2090-004X

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Purpose: To measure and compare the extent of retinal neovascularization using optical coherence tomography angiography (OCTA) between patients with good postoperative outcomes for proliferative diabetic retinopathy (PDR) requiring surgical treatment and patients with vitreous hemorrhage (VH). Methods: This retrospective study included patients who were diagnosed with PDR between January 2022 and December 2023 and underwent vitreous surgery. Cases that developed postoperative VH were classified as the VH group, and cases with good postoperative progress were classified as the control group. The extent of retinal neovascularization was measured from preoperative and postoperative images of the two groups taken by OCTA measured with a widefield optical coherence tomography (Canon, Xephilio OCT-A1), and a comparative study was conducted. Results: The VH group consisted of 8 patients with 11 eyes (4 men and 4 women) with a mean age of 49.7 ± 14.2 years, while the control group consisted of 23 patients with 26 eyes (19 men and 4 women) with a mean age of 56.9 ± 11.8 years. The preoperative retinal neovascular area was 50,233.7 ± 38,581.1 (pixels) in the VH group and 17,155.4 ± 27,950.2 (pixels) in the control group, showing a significant difference (p=0.046). The postoperative retinal neovascular area was 36,315.7 ± 44,311.8 (pixels) in the VH group and 2261.0 ± 9072.2 (pixels) in the control group, showing a significant difference (p=0.046), but there was no significant difference in the reduction rate of the neovascular area before and after surgery (p=0.30). Conclusions: In PDR developing VH after vitrectomy surgery, the appearance of neovascularization seen on pre- and postoperative OCTA is significantly more extensive than in cases that do not develop postoperative VH, and OCTA may be useful for preoperative evaluation.

    DOI: 10.1155/joph/7839246

    PubMed

  • Immunohistochemical expression of Fibrillin-1 in idiopathic epiretinal membranes.

    Tien LV, Yamamoto M, Tagami M, Misawa N, Honda S

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie   2024.10( ISSN:0721-832X

  • 特集 眼部悪性腫瘍の診断と治療 2 眼付属器リンパ腫:MALTリンパ腫とDLBCLを中心に

    田上 瑞記

    眼科   66 ( 10 )   969 - 975   2024.10( ISSN:00164488

  • Artificial intelligence-based differential diagnosis of orbital MALT lymphoma and IgG4 related ophthalmic disease using hematoxylin-eosin images.

    Mizuki Tagami, Mizuho Nishio, Atsuko Yoshikawa, Norihiko Misawa, Atsushi Sakai, Yusuke Haruna, Mami Tomita, Atsushi Azumi, Shigeru Honda

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie   262 ( 10 )   3355 - 3366   2024.10( ISSN:0721-832X

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    PURPOSE: To investigate the possibility of distinguishing between IgG4-related ophthalmic disease (IgG4-ROD) and orbital MALT lymphoma using artificial intelligence (AI) and hematoxylin-eosin (HE) images. METHODS: After identifying a total of 127 patients from whom we were able to procure tissue blocks with IgG4-ROD and orbital MALT lymphoma, we performed histological and molecular genetic analyses, such as gene rearrangement. Subsequently, pathological HE images were collected from these patients followed by the cutting out of 10 different image patches from the HE image of each patient. A total of 970 image patches from the 97 patients were used to construct nine different models of deep learning, and the 300 image patches from the remaining 30 patients were used to evaluate the diagnostic performance of the models. Area under the curve (AUC) and accuracy (ACC) were used for the performance evaluation of the deep learning models. In addition, four ophthalmologists performed the binary classification between IgG4-ROD and orbital MALT lymphoma. RESULTS: EVA, which is a vision-centric foundation model to explore the limits of visual representation, was the best deep learning model among the nine models. The results of EVA were ACC = 73.3% and AUC = 0.807. The ACC of the four ophthalmologists ranged from 40 to 60%. CONCLUSIONS: It was possible to construct an AI software based on deep learning that was able to distinguish between IgG4-ROD and orbital MALT. This AI model may be useful as an initial screening tool to direct further ancillary investigations.

    DOI: 10.1007/s00417-024-06501-1

    PubMed

  • 眼窩腫瘤を発症したアグレッシブNK細胞白血病の1例

    春名 優甫, 田上 瑞記, 木成 玄, 冨田 真未, 坂井 淳, 田中 さやか, 本田 茂

    日本眼腫瘍学会誌   13   19 - 23   2024.09( ISSN:2187-3178

     More details

    症例は38歳男性。13ヵ月前に発熱・盗汗を認めアグレッシブNK細胞白血病(Aggressive Natural Killer Cell Leukemia:ANKL)の診断で同種骨髄移植と化学療法を施行した。10日前から左眼瞼腫脹および複視を自覚したため来院した。眼窩単純MRIにて左上眼瞼から眼窩上方にかけてT1強調画像で低信号・T2高信号、拡散制限を呈するびまん性腫瘤を認め,眼球が下方に偏位していた。週単位で左眼瞼腫脹は増悪し、1ヵ月後に眼窩腫瘤生検を施行した。病理組織検査では間質の線維性拡大を認める腺組織のみであり確定診断には至らなかった。プレドニゾロン経口投与を開始し眼瞼腫脹は一時的に改善したが3ヵ月後に再度増悪した。6ヵ月後に多発骨髄浸潤によるANKLの再発のため眼科通院は途絶え、1回の同種骨髄移植と化学療法が血液内科により行われ、眼瞼腫脹は改善したが、17ヵ月後に永眠した。(著者抄録)

  • 炎症・感染とこれからの眼科診療 眼炎症を克服するための精密医療の実現に向けて

    楠原 仙太郎, 松宮 亘, 吉川 敦子, 淺原 俊一郎, 木戸 良明, 小川 渉, 西庄 龍東, 曽谷 尭之, 岸 真椰, 橘 吉寿, 内匠 透, 金 景佑, 村井 佑輔, 荒井 美奈, 坂本 麻里, 盛 崇太朗, 牧 仁美, 今井 尚徳, 田上 瑞記, 園田 康平, 蕪城 俊克, 柳井 亮二, 丸山 和一, 金子 優, 篠原 正和, 浅井 義之, 中津井 雅彦, 早野 崇英, 柏木 賢治, 中村 誠

    日本眼科学会雑誌   128 ( 3 )   234 - 255   2024.03( ISSN:0029-0203

  • Serum PD-1 regulation and PD-1 expression of CD4+Foxp3+ regulatory T cells in patients in thyroid eye disease associated with immunosuppression treatment.

    Sakai A, Tagami M, Misawa N, Haruna Y, Tomita M, Honda S

    Frontiers in ophthalmology   4   1491053   2024

  • Relationship between vitreous interleukin-6 levels and vitreous particles findings on widefield optical coherence tomography in posterior uveitis.

    Tomita M, Tagami M, Misawa N, Sakai A, Haruna Y, Honda S

    PloS one   19 ( 1 )   e0297201   2024

  • Stromal area differences with epithelial-mesenchymal transition gene changes in conjunctival and orbital mucosa-associated lymphoid tissue lymphoma.

    Mizuki Tagami, Hiroaki Kasashima, Anna Kakehashi, Atsuko Yoshikawa, Mizuho Nishio, Norihiko Misawa, Atsushi Sakai, Hideki Wanibuchi, Masakazu Yashiro, Atsushi Azumi, Shigeru Honda

    Frontiers in oncology   14   1277749 - 1277749   2024( ISSN:2234-943X

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    PURPOSE: To examine the molecular biological differences between conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma and orbital MALT lymphoma in ocular adnexa lymphoma. METHODS: Observational case series. A total of 129 consecutive, randomized cases of ocular adnexa MALT lymphoma diagnosed histopathologically between 2008 and 2020.Total RNA was extracted from formalin-fixed paraffin-embedded tissue from ocular adnexa MALT lymphoma, and RNA-sequencing was performed. Orbital MALT lymphoma gene expression was compared with that of conjunctival MALT lymphoma. Gene set (GS) analysis detecting for gene set cluster was performed in RNA-sequence. Related proteins were further examined by immunohistochemical staining. In addition, artificial segmentation image used to count stromal area in HE images. RESULTS: GS analysis showed differences in expression in 29 GS types in primary orbital MALT lymphoma (N=5,5, FDR q-value <0.25). The GS with the greatest difference in expression was the GS of epithelial-mesenchymal transition (EMT). Based on this GS change, immunohistochemical staining was added using E-cadherin as an epithelial marker and vimentin as a mesenchymal marker for EMT. There was significant staining of vimentin in orbital lymphoma (P<0.01, N=129) and of E-cadherin in conjunctival lesions (P=0.023, N=129). Vimentin staining correlated with Ann Arbor staging (1 versus >1) independent of age and sex on multivariate analysis (P=0.004). Stroma area in tumor were significant difference(P<0.01). CONCLUSION: GS changes including EMT and stromal area in tumor were used to demonstrate the molecular biological differences between conjunctival MALT lymphoma and orbital MALT lymphoma in ocular adnexa lymphomas.

    DOI: 10.3389/fonc.2024.1277749

    PubMed

  • Machine Learning Model with Texture Analysis for Automatic Classification of Histopathological Images of Ocular Adnexal Mucosa-associated Lymphoid Tissue Lymphoma of Two Different Origins.

    Mizuki Tagami, Mizuho Nishio, Atsuko Katsuyama-Yoshikawa, Norihiko Misawa, Atsushi Sakai, Yusuke Haruna, Atsushi Azumi, Shigeru Honda

    Current eye research   48 ( 12 )   1195 - 1202   2023.12( ISSN:0271-3683

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    PURPOSE: The purpose of this study was to develop artificial intelligence algorithms that can distinguish between orbital and conjunctival mucosa-associated lymphoid tissue (MALT) lymphomas in pathological images. METHODS: Tissue blocks with residual MALT lymphoma and data from histological and flow cytometric studies and molecular genetic analyses such as gene rearrangement were procured for 129 patients treated between April 2008 and April 2020. We collected pathological hematoxylin and eosin-stained (HE) images of lymphoma from these patients and cropped 10 different image patches at a resolution of 2048 × 2048 from pathological images from each patient. A total of 990 images from 99 patients were used to create and evaluate machine-learning models. Each image patch of three different magnification rates at ×4, ×20, and ×40 underwent texture analysis to extract features, and then seven different machine-learning algorithms were applied to the results to create models. Cross-validation on a patient-by-patient basis was used to create and evaluate models, and then 300 images from the remaining 30 cases were used to evaluate the average accuracy rate. RESULTS: Ten-fold cross-validation using the support vector machine with linear kernel algorithm was identified as the best algorithm for discriminating between conjunctival mucosa-associated lymphoid tissue and orbital MALT lymphomas, with an average accuracy rate under cross-validation of 85%. There were ×20 magnification HE images that were more accurate in distinguishing orbital and conjunctival MALT lymphomas among ×4, ×20, and ×40. CONCLUSION: Artificial intelligence algorithms can successfully distinguish HE images between orbital and conjunctival MALT lymphomas.

    DOI: 10.1080/02713683.2023.2246696

    PubMed

  • En-face widefield optical coherence tomography angiography for understanding vascular networks changes in two cases of acute retinal necrosis.

    Mami Tomita, Mizuki Tagami, Norihiko Misawa, Atsushi Sakai, Yusuke Haruna, Shigeru Honda

    Journal of ophthalmic inflammation and infection   13 ( 1 )   9 - 9   2023.03( ISSN:1869-5760

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    PURPOSE: The present study assesses the utility of en-face widefield optical coherence tomography angiography (OCTA) imaging for evaluating the retinal vascular network during the course of treatment in acute retinal necrosis(ARN). OBSERVATIONS: OCTA images of two cases of acute retinal necrosis were analyzed. Case 1 was a 15-year-old male with visual crowding in his right eye who had best-corrected visual acuity of 16/20 and intraocular pressure of 25 mmHg in his right eye on initial evaluation. Case 2 was a 57-year-old male with visual crowding in his left eye who had best-corrected visual acuity of 20/20 in his left eye on initial examination and intraocular pressure of 19.3 mmHg. In both patients, dynamic changes could be tracked by en-face ultra-widefield OCTA imaging before and up to 1 year after surgical treatment. The images showed arteriovenous anastomosis and the nonperfused area on the surface of the retina. CONCLUSIONS AND IMPORTANCE: En-face widefield OCTA is useful for monitoring the structure of retinal vessels over time in acute retinal necrosis. Wide-angle OCTA is used to non-invasively examine retinal vascular dynamic changes in ARN. OCTA artifacts due to intraocular inflammation appeared, making interpretation difficult. These will remain as issues in the future. It seems difficult for a while to completely replace FA due to the problem of image clarity.

    DOI: 10.1186/s12348-023-00331-8

    PubMed

  • Relationship between Vitreous IL-6 Levels, Gender Differences and C-Reactive Protein (CRP) in a Blood Sample of Posterior Uveitis.

    Atsushi Sakai, Mizuki Tagami, Atsuko Katsuyama-Yoshikawa, Norihiko Misawa, Yusuke Haruna, Atsushi Azumi, Shigeru Honda

    Journal of clinical medicine   12 ( 5 )   2023.02( ISSN:2077-0383

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    This study retrospectively determined the relationship between vitreous IL-6 levels and clinical and laboratory data collected from uveitis patients. We examined an unknown cause of posterior uveitis, collecting vitreous fluid to investigate vitreous IL-6 levels. The samples were analyzed in consideration of clinical and laboratory factors, such as the male/female ratio. The present study included 82 eyes from 77 patients with a mean age of 66.20 ± 15.41 years. The IL-6 concentrations of the vitreous specimens were 6255.0 ± 14,108.3 pg/mL in males and 277.6 ± 746.3 pg/mL in females, which was found to be a statistically significant difference (p = 0.048) (n = 82). There was also a statistically significant correlation between vitreous IL-6 concentrations, serum C-reactive protein (CRP) value and white blood cell counts (WBCs) (n = 82). In multivariate analysis, vitreous IL-6 levels were significantly correlated with gender and CRP in all cases (p = 0.048 and p < 0.01, respectively) and were also significantly correlated with CRP in non-infectious uveitis (p < 0.01). In infectious uveitis, there were no significant differences between IL-6 level and several variables. Vitreous IL-6 concentrations were higher in males than in females in all cases. In non-infectious uveitis, vitreous IL-6 levels were correlated with serum CRP. These results might suggest that intraocular IL-6 levels depend on gender differences in posterior uveitis, and intraocular IL-6 levels in non-infectious uveitis may reflect systemic inflammations, including increased serum CRP.

    DOI: 10.3390/jcm12051720

    PubMed

  • Relationship between ultra-widefield optical coherence tomography and ophthalmoscopy for detecting posterior inflammation in posterior uveitis and panuveitis.

    Norihiko Misawa, Mizuki Tagami, Atsushi Sakai, Yusuke Haruna, Shigeru Honda

    PloS one   18 ( 2 )   e0281714   2023

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    PURPOSE: To confirm the utility of ultra-widefield optical coherence tomography (W-OCT) for diagnosing uveitis. METHOD: We retrospectively studied patients who had been diagnosed with uveitis and had undergone W-OCT. All patients had visited at Osaka Metropolitan University between January 2019 and January 2022. On W-OCT, vitreous opacity ("W-OCT VO") and the presence of vitreous cells ("W-OCT Cells") were identified by three specialists. We compared findings from ophthalmoscopy ("Ophthalmoscopic findings") and fluorescein angiography ("FAG findings") with those from W-OCT. RESULTS: This study investigated 132 eyes from 68 patients (34 males, 34 females; mean age, 53.97±22.71 years). Vitreous cells in posterior uveitis and panuveitis differed significantly between "W-OCT Cells" and "Ophthalmoscopic findings" for all cases (P = 0.00014). Vitreous opacities in posterior uveitis and panuveitis did not differ significantly between "W-OCT VO" and "Ophthalmoscopic findings" (P = 0.144) for all cases. Compared to "Ophthalmoscopic findings", "W-OCT Cells" offered 51.1% sensitivity and 66.7% specificity for all cases (p<0.01). Compared to "Ophthalmoscopic findings", "W-OCT VO" offered 78.6% sensitivity and 30% specificity for all cases (p = 0.19). In addition, "W-OCT Cells" did not differ significantly from "FAG findings" for all cases (P = 0.424). CONCLUSION: W-OCT was shown to offer significantly greater sensitivity than ophthalmoscopy for detecting vitreous cells. The results of this study may add an option for the evaluation of uveitis.

    DOI: 10.1371/journal.pone.0281714

    PubMed

  • Two Cases of Extremely High-IL-6 Pan-uveitis with Subretinal Exudation and Cell Migration.

    Mizuki Tagami, Norihiko Misawa, Atsushi Sakai, Shigeru Honda

    Ocular immunology and inflammation   30 ( 7-8 )   1577 - 1581   2022.10( ISSN:0927-3948

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Purpose: To describe two cases of extremely high-IL-6 pan-uveitis with subretinal exudation and cell migration.Methods: Pre-operative and postoperative images and IL-6 values in vitreous samples of two pan-uveitis cases were analyzed.Results: Case 1 was a 76-year-old man with blurry vision in his right eye. Fundus examination and optical coherence tomography showed vitreous opacification with vitreous cells and the presence of a white-yellowish retinal exudate with peripheral choroidal detachment all around. The IL-6 value was 16,600 pg/ml. Case 2 was a 63-year-old man with blurry vision in his right eye. On fundus examination, there was severe vitreous opacification in his right eye. The IL-6 value was 26,600 pg/ml. Importantly, there was good responsiveness to steroids and the TNF inhibitor.Conclusion: Unclassified intraocular inflammation might include a new category of disease with unilateral pan-uveitis with good response to steroid therapy and extremely high vitreous IL-6 values.

    DOI: 10.1080/09273948.2021.1909071

    PubMed

  • En Face Images Using Ultra-Widefield Optical Coherence Tomography in 2 Cases of Traumatic Hypotony Maculopathy before and after Surgical Intervention.

    Yuri Nagatomi, Mizuki Tagami, Norihiko Misawa, Atsushi Sakai, Yusuke Haruna, Shigeru Honda

    Case reports in ophthalmology   13 ( 3 )   963 - 969   2022.09( ISSN:1663-2699

     More details

    International / domestic magazine:International journal  

    The aim was to investigate the structural changes of the retina using en face ultra-widefield optical coherence tomography (OCT) images during the treatment of hypotony maculopathy with traumatic cyclodialysis. Case 1 was a 43-year-old male patient with visual crowding in his left eye (metallic wire injury that occurred 3 weeks previously) who was referred to our department. Although best-corrected visual acuity was 20/20 in his left eye on initial evaluation, intraocular pressure was 6 mm Hg. Case 2 was a 20-year-old male patient with visual crowding in his left eye (baseball ball injury that occurred 4 weeks previously) who was referred to our department. Although best-corrected visual acuity was 16/20 in his left eye on initial examination, intraocular pressure was 5 mm Hg. Surgical interventions were performed in both cases. En face ultra-widefield OCT images were able to be used to trace dynamic changes before the intervention and up to 1 year later. The images obtained in these two cases made it possible to confirm the progress from wrinkles on the surface of the retina to normalization of vascular structure and improvement of ellipsoid zone disruption. En face ultra-widefield OCT is useful for monitoring multilayer structures of the retina in hypotony maculopathy cases.

    DOI: 10.1159/000527094

    PubMed

  • EPIDERMAL GROWTH FACTOR RECEPTOR EXPRESSION IN A CASE OF FOCAL NODULAR GLIOSIS OF THE RETINA. Reviewed

    Mizuki Tagami, Norihiko Misawa, Saki Noma-Ishikura, Satoshi Honda, Satoru Kase, Shigeru Honda

    Retinal cases & brief reports   16 ( 3 )   375 - 378   2022.05( ISSN:1935-1089

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    PURPOSE: To describe the immunohistochemical profile in a case with focal nodular gliosis (FNG) of the retina. METHODS: A 56-year-old female patient presented with vitreoretinal tractional syndrome with FNG of the retina. After resection of the retinal tumor tissue during the 25-G pars plana vitrectomy, immunohistochemistry using anti-epidermal growth factor receptor (EGFR), p-53, Ki67, glial fibrillary acid protein (GFAP), CD34, and vascular endothelial growth factor antibodies was performed in the excised tissue of the FNG of the retina. RESULTS: Histopathological analysis of the tumor led to a diagnosis of FNG of the retina. Spindle cells of the tumor exhibited strong positive staining for glial fibrillary acid protein, and there was local staining for CD34 in the endothelial cells in the blood vessels. The epidermal growth factor receptor and vascular endothelial growth factor immunoreactivity were strongly observed in the endothelial cells. CONCLUSION: This study demonstrated epidermal growth factor receptor expression in eyes with FNG of the retina. Oncogenic epidermal growth factor receptor might trigger and amplify the expression and function of endothelial vascular endothelial growth factor.

    DOI: 10.1097/ICB.0000000000000987

    PubMed

  • Safety and efficacy of 27-gauge transconjunctival vitrectomy for the diagnosis of posterior uveitis or pan uveitis of unknown origin.

    Atsushi Sakai, Mizuki Tagami, Norihiko Misawa, Manabu Yamamoto, Takeya Kohno, Shigeru Honda

    BMC ophthalmology   22 ( 1 )   178 - 178   2022.04

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Diagnostic vitrectomy is an important method for evaluating uveitis, and its diagnostic utility is high regardless of whether the uveitis is infectious or non-infectious. The course of diagnostic vitreous surgery with 27-gauge pars plana vitrectomy and perioperative complications is reported. METHODS: An observational retrospective study of patients who underwent 27-gauge diagnostic vitrectomy due to atypical intraocular inflammation was conducted. The final diagnosis rate, complications due to surgery, preoperative visual acuity, and postoperative visual acuity (1 month and 6 months after surgery) were examined retrospectively. RESULTS: Diagnostic vitreous surgery was performed in 32 patients and 35 eyes (14 males and 18 females, age 14-85 years, median 67 years) during the study period. The average operation time was 52 min for 19 eyes with cataract surgery and 35 min for 16 eyes without cataract surgery. Preoperative log(minimum angle of resolution [MAR]) visual acuity was 0.84 ± 0.87, 1-month postoperative logMAR visual acuity was 0.41 ± 0.55 (p = 0.004, n = 28), and 6-month postoperative average logMAR visual acuity was 0.45 ± 0.73 (p = 0.012, n = 15). The diagnosis was made by diagnostic vitrectomy in 19 cases (54%). Postoperative complications were observed in 2 of 35 postoperative patients (5%); one involved increased intraocular pressure, and the other case involved vitreous hemorrhage of the eye, necessitating reoperation. CONCLUSION: Diagnostic 27-gauge vitrectomy could be effective for evaluating intraocular inflammation.

    DOI: 10.1186/s12886-022-02405-y

    PubMed

  • Insights into Current Management Strategies for Dysthyroid Optic Neuropathy: A Review.

    Mizuki Tagami, Shigeru Honda, Atsushi Azumi

    Clinical ophthalmology (Auckland, N.Z.)   16   841 - 850   2022( ISSN:1177-5467

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Dysthyroid optic neuropathy (DON) is a potentially sight-threatening eye disease associated with Graves' orbitopathy (GO). DON is not common in GO patients, reportedly occurring in only about 5% of patients. The pathogenesis of severe DON is considered to involve both muscular nerve strangulation and impaired blood flow. There is some objective grading of physical examination findings and the severity of GO, including a clinical activity score (CAS) and EUropean Group On Graves' Orbitopathy (EUGOGO), but no specialized protocol completely characterizes DON. Most clinicians have decided that the combination of clinical activity findings, including visual acuity, color vision, and central critical fusion frequency, and radiological findings, including magnetic resonance imaging (MRI), can be used to diagnose DON. MRI has the most useful findings, with T2-weighted and fat-suppressed images using short-tau inversion recovery (STIR) sequences enabling detection of extraocular changes including muscle and/orbital fat tissue swelling and inflammation and, therefore, disease activity. The first-choice treatment for DON is intravenous administration of steroids, with or without radiotherapy. Unfortunately, refractoriness to this medical treatment may indicate the need for immediate orbital decompression within 2 weeks. Especially in the acute phase of DON, thyroid function is often unstable, and the surgeon must always assume the risk of general anesthesia and intra- and post-operative management. In addition, there are currently many possible therapeutic options, including molecular-targeted drugs. The early introduction and combination of these immunomodulators, including Janus kinase inhibitors and insulin-like growth factor-1 receptor antibody (teprotumumab), may be effective for GO with DON. However, this is still under investigation, and the number of case reports is small. It is possible that these options could reduce systemic adverse events due to unfocused glucocorticoid administration. The pathophysiology of DON is not yet fully understood, and further studies of its treatment and long-term visual function prognosis are needed.

    DOI: 10.2147/OPTH.S284609

    PubMed

  • FOXP3 and CXCR4-positive regulatory T cells in the tumor stroma as indicators of tumor immunity in the conjunctival squamous cell carcinoma microenvironment.

    Mizuki Tagami, Anna Kakehashi, Atsuko Katsuyama-Yoshikawa, Norihiko Misawa, Atsushi Sakai, Hideki Wanibuchi, Atsushi Azumi, Shigeru Honda

    PloS one   17 ( 3 )   e0263895   2022

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Conjunctival squamous cell carcinoma (SCC) is the most common ocular surface neoplasia. The purpose of this retrospective study was to examine the role of regulatory T cell (Treg) activity in tumor immunity and investigate the tumor microenvironment as a new treatment focus in conjunctival SCC. Cancer progression gene array and immunohistochemical analyses of FOXP3 as a Treg marker, CD8 as a tumor-infiltrating lymphocyte marker, and CXCR4 expression on activated Tregs were conducted in a series of 31 conjunctival SCC cases. The objective was to investigate the immunoreactive response in tumor cells and stromal cells in the cancer microenvironment. The stroma ratio in tumor cells was investigated by monitoring α-smooth muscle actine (SMA) expression between carcinoma in situ (Tis) and advanced carcinoma (Tadv) (P<0.01). No significant change in PD-L1 expression was observed in this study (P = 0.15). Staining patterns of FOXP3, CD8, and CXCR4 were examined separately between tumor cells and stromal cells in SCC tumors. Differences in staining of FOXP3 in Tregs and CD8 in tumor-infiltrating lymphocytes in tumor stroma in the Tis group were observed compared with the Tadv group (each P<0.01). In addition, double immunostaining of CXCR4/FOXP3 was correlated with progression-free survival (P = 0.049). Double immunostaining of CXCR4/FOXP3 correlated with American Joint Committee on Cancer T-stage, independent of age or Ki67 index (P<0.01). Our results show that FOXP3 and the CXCR4/FOXP3 axis are important pathologic and prognostic factors of ocular surface neoplasia, including SCC. The tumor microenvironment of conjunctival SCC should be considered in the future development of treatment options.

    DOI: 10.1371/journal.pone.0263895

    PubMed

  • Visual outcomes and choroidal thickness associated with human leukocyte antigen DRB1*04 in unclassifiable uveitis in Japanese patients Reviewed

    Misawa Norihiko, Tagami Mizuki, Sakai Atsushi, Kohno Takeya, Honda Shigeru

    BMC OPHTHALMOLOGY   21 ( 1 )   457   2021.12

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12886-021-02222-9

    PubMed

  • Visual outcomes and choroidal thickness associated with human leukocyte antigen DRB1*04 in unclassifiable uveitis in Japanese patients.

    Norihiko Misawa, Mizuki Tagami, Atsushi Sakai, Takeya Kohno, Shigeru Honda

    BMC ophthalmology   21 ( 1 )   457 - 457   2021.12

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    PURPOSE: Human leukocyte antigen (HLA) and immunity are related. Uveitis is also closely related to immunity. For example, the common presence of human leukocyte antigen (HLA)-DRB1*04 in the immune response is well known. The aim of this study was to investigate the relationship between visual prognosis and various HLA alleles before and after therapy in patients with unclassifiable uveitis, excluding those with Vogt-Koyanagi-Harada (VKH) disease. METHODS: This retrospective case series included 42 eyes from 22 consecutive patients with unclassifiable uveitis, excluding those with VKH disease. Visual acuity (VA), sex, refractive error, central retinal thickness (CRT), central choroidal thickness (CCT), and duration from onset to treatment were measured at initial and 6-month visits. Mean values of parameters were compared at each visit. Genotyping was performed by polymerase chain reaction amplification with sequence-specific primers. RESULTS: DRB1*04 showed a dominant change. No significant difference was observed in the other alleles. In DRB1*04, The mean differences in initial CCT, 6-month CCT, and 6-month VA showed statistically significant difference was found in best-corrected visual acuity (BCVA) between DRB1*04+ and DRB1*04- at the first visit. BCVA values at baseline and at the final visit were 0.13 ± 0.29 and 0.20 ± 0.36 in the DRB1*04+ and 0.00045 ± 0.20 and - 0.058 ± 0.11 in the DRB1*04- groups(p = 0.00465). Central Choroidal Thickness (CCT) values pretreatment and at the final visit after treatment were (pretreatment:361.00 ± 361.0 μm,after treatment: 286.00 ± 106.53 μm, p = 0.0174) in the DRB1*04+ group, and (pretreatment:281.3 ± 139.68 μm,after treatment:223.85 ± 99.034 μm, p = 0.0426) in the DRB1*04- group, respectively, indicating changes between baseline and the final visit. CCT was significantly greater in the DRB1*04+ group at both the initial visit and at 6 months. Multivariate analysis showed a significant difference between the presence or absence of DRB1*04 and sex. CONCLUSION: HLA-DRB1*04 allele may affect visual prognosis and CCT in unclassifiable uveitis.

    DOI: 10.1186/s12886-021-02222-9

    PubMed

  • Discovery of widespread transcription initiation at microsatellites predictable by sequence-based deep neural network

    Grapotte M.

    Nature Communications   12 ( 1 )   2021.12

     More details

  • 様々な体位の造影MRIで診断した自覚症状の乏しい眼窩静脈奇形(Orbital Venous Malformation with Obscure Clinical Symptoms Diagnosed by Contrast-enhanced Magnetic Resonance Imaging in a Different Body Position)

    Kyo Akika, Yoshida Yusaku, Tagami Mizuki, Hamuro Masao, Honda Shigeru

    Osaka City Medical Journal   67 ( 2 )   91 - 96   2021.12( ISSN:0030-6096

     More details

    症例は54歳女性で、左眼瞼痛、左眼瞼腫脹、吐き気が出現したため当科を受診した。患者は以前から、うつ伏せで寝た際に左眼周囲に違和感を覚えていた。最高矯正視力は右0.9、左1.0で、眼運動はいずれも正常であり、左眼瞼に軽度の皮下出血がみられたが眼球突出はみられなかった。抗生物質による治療で症状が改善したため、当初は眼窩蜂巣炎が疑われた。造影前のCTとMRIでは確定診断に至らなかった。2週間後、患者は下を向くと悪化する左眼瞼痛を訴えた。様々な体位で造影MRIを行ったところ、病変は腹臥位で大きくなり、病変は血流が遅かった。病変への動脈供給が明らかでないことから、眼窩静脈奇形と診断した。その後、体位を変えても他の臨床症状を伴わない左眼窩痛を繰り返し訴えたため、脳神経外科に紹介され、外科的治療を受けることとなった。しかし、血管造影では眼窩腫瘍への血管流入は描出されず、無治療で経過観察することとなった。

  • VKHを除くぶどう膜炎におけるHLA-B1*04アレルと視力予後との関係

    三澤 宣彦, 田上 瑞記, 坂井 淳, 山本 学, 河野 剛也, 本田 茂

    眼科臨床紀要   14 ( 11 )   781 - 782   2021.11( ISSN:1882-5176

  • Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva Reviewed

    Harada Naonori, Tagami Mizuki, Koh Hideo, Ohsawa Masahiko, Hino Masayuki, Nakamae Hirohisa

    INTERNATIONAL JOURNAL OF HEMATOLOGY   114 ( 4 )   413 - 414   2021.10( ISSN:0925-5710

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12185-021-03208-5

    PubMed

  • Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva.

    Naonori Harada, Mizuki Tagami, Hideo Koh, Masahiko Ohsawa, Masayuki Hino, Hirohisa Nakamae

    International journal of hematology   114 ( 4 )   413 - 414   2021.10( ISSN:0925-5710

     More details

    International / domestic magazine:Domestic journal  

    DOI: 10.1007/s12185-021-03208-5

    PubMed

  • Expression of thrombospondin-1 in conjunctival squamous cell carcinoma is correlated to the Ki67 index and associated with progression-free survival.

    Mizuki Tagami, Anna Kakehashi, Atsushi Sakai, Norihiko Misawa, Atsuko Katsuyama-Yoshikawa, Hideki Wanibuchi, Atsushi Azumi, Shigeru Honda

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie   259 ( 10 )   3127 - 3136   2021.10( ISSN:0721-832X

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    PURPOSE: Conjunctival squamous cell carcinoma (SCC) is primarily treated with surgical resection. SCC has various stages, and local recurrence is common. The purpose of this study was to investigate thrombospondin-1 expression and its association with prognosis. METHODS: In this retrospective study, a gene expression array along with immunohistochemistry were performed for the evaluation of thrombospondin-1 expression, localization, as well as Ki67 labeling cell indices in carcinoma in situ (Tis) and advanced conjunctival SCC (Tadv). The presence or absence and intensity of cytoplasmic and nuclear staining in tumor cells were also divided into groups with a score of 0-3 and semi-quantitatively analyzed to investigate intracellular staining patterns. The association between thrombospondin-1 expression and tumor progression in a series of 31 conjunctival SCCs was further investigated. RESULTS: All 31 patients in the cohort (100%) were East Asian. A simple comparison between Tis and Tadv demonstrated significant differences in expressions of 45 genes, including thrombospondin-1 (p < 0.01). In this cohort, 30/31 tumors were positive (96%) for thrombospondin-1. Furthermore, thrombospondin-1 intracellular staining pattern analysis scores were 2.12 and 0.96 for nuclear and cytoplasmic staining, respectively, with a significant difference observed between Tis and Tadv (p < 0.01). Alteration of the Ki67 labeling index was significantly correlated with that of the thrombospondin-1 cytoplasmic score (p = 0.030). Furthermore, univariate Cox regression analysis showed a significant correlation between thrombospondin-1 staining and progression-free survival (p = 0.026) and final orbital exenteration (p = 0.019). CONCLUSIONS: The present results demonstrated that thrombospondin-1 is a potential molecular target in the pathology of conjunctival SCC, in addition to serving as a prognostic factor.

    DOI: 10.1007/s00417-021-05236-7

    PubMed

  • ぶどう膜炎患者における視力予後とHLA-B1*04アレイとの関係

    三澤 宣彦, 田上 瑞記, 坂井 淳, 山本 学, 河野 剛也, 本田 茂

    眼科臨床紀要   14 ( 7 )   464 - 464   2021.07( ISSN:1882-5176

  • Expression of thrombospondin-1 in conjunctival squamous cell carcinoma is correlated to the Ki67 index and associated with progression-free survival Reviewed

    Tagami Mizuki, Kakehashi Anna, Sakai Atsushi, Misawa Norihiko, Katsuyama-Yoshikawa Atsuko, Wanibuchi Hideki, Azumi Atsushi, Honda Shigeru

    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY   2021.05( ISSN:0721-832X

     More details

    Publishing type:Research paper (scientific journal)  

    PURPOSE: Conjunctival squamous cell carcinoma (SCC) is primarily treated with surgical resection. SCC has various stages, and local recurrence is common. The purpose of this study was to investigate thrombospondin-1 expression and its association with prognosis. METHODS: In this retrospective study, a gene expression array along with immunohistochemistry were performed for the evaluation of thrombospondin-1 expression, localization, as well as Ki67 labeling cell indices in carcinoma in situ (Tis) and advanced conjunctival SCC (Tadv). The presence or absence and intensity of cytoplasmic and nuclear staining in tumor cells were also divided into groups with a score of 0-3 and semi-quantitatively analyzed to investigate intracellular staining patterns. The association between thrombospondin-1 expression and tumor progression in a series of 31 conjunctival SCCs was further investigated. RESULTS: All 31 patients in the cohort (100%) were East Asian. A simple comparison between Tis and Tadv demonstrated significant differences in expressions of 45 genes, including thrombospondin-1 (p < 0.01). In this cohort, 30/31 tumors were positive (96%) for thrombospondin-1. Furthermore, thrombospondin-1 intracellular staining pattern analysis scores were 2.12 and 0.96 for nuclear and cytoplasmic staining, respectively, with a significant difference observed between Tis and Tadv (p < 0.01). Alteration of the Ki67 labeling index was significantly correlated with that of the thrombospondin-1 cytoplasmic score (p = 0.030). Furthermore, univariate Cox regression analysis showed a significant correlation between thrombospondin-1 staining and progression-free survival (p = 0.026) and final orbital exenteration (p = 0.019). CONCLUSIONS: The present results demonstrated that thrombospondin-1 is a potential molecular target in the pathology of conjunctival SCC, in addition to serving as a prognostic factor.

    DOI: 10.1007/s00417-021-05236-7

    PubMed

  • Two Cases of Extremely High-IL-6 Pan-uveitis with Subretinal Exudation and Cell Migration Reviewed

    Tagami Mizuki, Misawa Norihiko, Sakai Atsushi, Honda Shigeru

    OCULAR IMMUNOLOGY AND INFLAMMATION   1 - 5   2021.04( ISSN:0927-3948

     More details

    Publishing type:Research paper (scientific journal)  

    Purpose: To describe two cases of extremely high-IL-6 pan-uveitis with subretinal exudation and cell migration.Methods: Pre-operative and postoperative images and IL-6 values in vitreous samples of two pan-uveitis cases were analyzed.Results: Case 1 was a 76-year-old man with blurry vision in his right eye. Fundus examination and optical coherence tomography showed vitreous opacification with vitreous cells and the presence of a white-yellowish retinal exudate with peripheral choroidal detachment all around. The IL-6 value was 16,600 pg/ml. Case 2 was a 63-year-old man with blurry vision in his right eye. On fundus examination, there was severe vitreous opacification in his right eye. The IL-6 value was 26,600 pg/ml. Importantly, there was good responsiveness to steroids and the TNF inhibitor.Conclusion: Unclassified intraocular inflammation might include a new category of disease with unilateral pan-uveitis with good response to steroid therapy and extremely high vitreous IL-6 values.

    DOI: 10.1080/09273948.2021.1909071

    PubMed

  • Clinical benefit for clinical sequencing using cancer panel testing Reviewed

    Nishimura Sadaaki, Sugimoto Atsushi, Kushiyama Shuhei, Togano Shingo, Kuroda Kenji, Yamamoto Yurie, Yamauchi Makoto, Sumi Toshiyuki, Kaneda Hiroyasu, Kawaguchi Tomoya, Kato Minoru, Tagami Mizuki, Oebisu Naoto, Hoshi Manabu, Kimura Kenjiro, Kubo Shoji, Muguruma Kazuya, Takashima Tsutomu, Ohira Masaichi, Yashiro Masakazu

    PLOS ONE   16 ( 2 )   e0247090   2021.02( ISSN:1932-6203

     More details

    Publishing type:Research paper (scientific journal)  

    BACKGROUND: Clinical sequencing using a panel of genes has recently been applied worldwide for patients with refractory solid tumors, but the significance of clinical sequencing using gene panel testing remains uncertain. Here we sought to clarify the feasibility and utility of clinical sequencing in the treatment of refractory tumors at our hospital. METHODS: A total of 39 patients with advanced solid tumors treated at our hospital between 2018 and 2020 were enrolled in the clinical sequencing. Among them, we identified 36 patients whose tissue samples were of suitable quality for clinical sequencing, and we analyzed the genomic profiles of these tumors. RESULTS: Pathogenic alterations were detected in 28 (78%) of the 36 patients. The most common mutation was TP53 (55%), followed by KRAS (22%), and the highest frequency of gene amplification was ERBB2 (17%). Nine of the 36 patients were identified as candidates for novel molecular-targeted therapy based on their actionable gene alterations, but only one case ended up receiving novel targeted therapy following the genetic tests. CONCLUSIONS: Our current results suggested that clinical sequencing might be useful for the detection of pathogenic alterations and the management of additional cancer treatment. However, molecular target based on actionable genomic alteration does not always bridge to subsequent therapy due to clinical deterioration, refusal for unapproved drug, and complexity of clinical trial access. Both improved optimal timing of clinical sequencing and a consensus about its off-label use might help patients receive greater benefit from clinical sequencing.

    DOI: 10.1371/journal.pone.0247090

    PubMed

  • FANTOM enters 20th year: Expansion of transcriptomic atlases and functional annotation of non-coding RNAs

    Abugessaisa I.

    Nucleic Acids Research   49 ( D1 )   D892 - D898   2021.01( ISSN:03051048

     More details

  • Clinical benefit for clinical sequencing using cancer panel testing.

    Sadaaki Nishimura, Atsushi Sugimoto, Shuhei Kushiyama, Shingo Togano, Kenji Kuroda, Yurie Yamamoto, Makoto Yamauchi, Toshiyuki Sumi, Hiroyasu Kaneda, Tomoya Kawaguchi, Minoru Kato, Mizuki Tagami, Naoto Oebisu, Manabu Hoshi, Kenjiro Kimura, Shoji Kubo, Kazuya Muguruma, Tsutomu Takashima, Masaichi Ohira, Masakazu Yashiro

    PloS one   16 ( 2 )   e0247090   2021

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: Clinical sequencing using a panel of genes has recently been applied worldwide for patients with refractory solid tumors, but the significance of clinical sequencing using gene panel testing remains uncertain. Here we sought to clarify the feasibility and utility of clinical sequencing in the treatment of refractory tumors at our hospital. METHODS: A total of 39 patients with advanced solid tumors treated at our hospital between 2018 and 2020 were enrolled in the clinical sequencing. Among them, we identified 36 patients whose tissue samples were of suitable quality for clinical sequencing, and we analyzed the genomic profiles of these tumors. RESULTS: Pathogenic alterations were detected in 28 (78%) of the 36 patients. The most common mutation was TP53 (55%), followed by KRAS (22%), and the highest frequency of gene amplification was ERBB2 (17%). Nine of the 36 patients were identified as candidates for novel molecular-targeted therapy based on their actionable gene alterations, but only one case ended up receiving novel targeted therapy following the genetic tests. CONCLUSIONS: Our current results suggested that clinical sequencing might be useful for the detection of pathogenic alterations and the management of additional cancer treatment. However, molecular target based on actionable genomic alteration does not always bridge to subsequent therapy due to clinical deterioration, refusal for unapproved drug, and complexity of clinical trial access. Both improved optimal timing of clinical sequencing and a consensus about its off-label use might help patients receive greater benefit from clinical sequencing.

    DOI: 10.1371/journal.pone.0247090

    PubMed

  • Expression, intracellular localization, and mutation of EGFR in conjunctival squamous cell carcinoma and the association with prognosis and treatment Reviewed

    Sakai Atsushi, Tagami Mizuki, Kakehashi Anna, Katsuyama-Yoshikawa Atsuko, Misawa Norihiko, Wanibuchi Hideki, Azumi Atsushi, Honda Shigeru

    PLOS ONE   15 ( 8 )   e0238120   2020.08( ISSN:1932-6203

     More details

    Publishing type:Research paper (scientific journal)  

    PURPOSE: Conjunctival squamous cell carcinoma (SCC) is primarily treated with surgical resection. SCC has various stages, and local recurrence is common. The purpose of this study was to determine molecular localization of epidermal growth factor receptor (EGFR) and the possibility of EGFR as a biomarker for the management of conjunctival SCC. METHODS: In this retrospective study, we performed immunohistochemistry to evaluate EGFR expression and localization in tumor cells, EGFR mutation-specific expression (E746-A750del and L858R), and human papillomavirus expression in a series of 29 conjunctival SCCs. RESULTS: All 29 tumors in our cohort were EGFR positive (100%). Twenty-one of 29 tumors (72%) showed focal EGFR staining, and seven (28%) showed diffuse EGFR staining. In addition, we calculated the percentages of the two most important mutations in EGFR (exon 19 746-A750del (8/29, 27.5%), exon 21 (L858R mutant (2/29, 6.8%)) in conjunctival SCCs. We observed that the translocation of EGFR from the membrane into the cytoplasm was related to clinical prognosis, as we detected correlations between EGFR cytoplasmic staining and final orbital exenteration and between decreased EGFR membrane staining and progression-free survival. CONCLUSIONS: EGFR is important in the pathology of ocular surface squamous neoplasia including SCC and is a prognostic factor. Increased understanding of EGFR mutations may have important implications for future treatment options.

    DOI: 10.1371/journal.pone.0238120

    PubMed

  • Rapid Regression of Scleral Melting Associated with Tumor Necrosis Factor-α in a Case of Surgically Induced Necrotizing Scleritis.

    Norihiko Misawa, Mizuki Tagami, Atsushi Sakai, Takeya Kohno, Shigeru Honda

    Case reports in ophthalmology   11 ( 2 )   418 - 422   2020.05( ISSN:1663-2699

     More details

    International / domestic magazine:International journal  

    PURPOSE: To report a case with rapid regression of scleral melting associated with tumor necrosis factor-α (TNF-α) in a surgically induced necrotizing scleritis (SINS) patient treated with local steroid therapy. CASE PRESENTATION: An 85-year-old male patient presented with conjunctival tumor in his right eye. Complete resection of the tumor lesion and conjunctival re-construction were performed. Local steroid drops were administered until 1 month after surgery, and a good clinical course was achieved. However, after stopping the local steroid, scleral melting to the uvea occurred on the center of the tumor-resected sclera. After diagnosing SINS, we immediately restarted his local steroid. After 2 weeks, there was a complete and rapid regression of the scleral melting. Following this episode, only local steroid therapy was continued for the treatment of SINS, with no recurrence observed after 6 months. Histopathological analysis revealed the infiltration of inflammatory cells during the acute phase, with TNF-α immune reactivity observed in the center of the melting site near the resected conjunctiva. CONCLUSION: We speculate that the observed changes were associated with the TNF-α that was present during the pathological state of SINS. Local steroid therapy may play a key role in the local immune balance in SINS.

    DOI: 10.1159/000509260

    PubMed

  • EPIDERMAL GROWTH FACTOR RECEPTOR EXPRESSION IN A CASE OF FOCAL NODULAR GLIOSIS OF THE RETINA. Reviewed

    Tagami M, Misawa N, Noma-Ishikura S, Honda S, Kase S, Honda S

    Retinal cases & brief reports   2020.02( ISSN:1935-1089

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/ICB.0000000000000987

    PubMed

  • Preoperative clinical factors and visual outcomes following orbital decompression with dysthyroid optic neuropathy. Reviewed

    Tagami M, Honda S, Azumi A

    BMC ophthalmology   20 ( 1 )   30   2020.01

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12886-020-1314-8

    PubMed

  • Preoperative clinical factors and visual outcomes following orbital decompression with dysthyroid optic neuropathy. Reviewed

    Mizuki Tagami, Shigeru Honda, Atsushi Azumi

    BMC ophthalmology   20 ( 1 )   30 - 30   2020.01

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: To investigate preoperative clinical factors and visual outcomes of Japanese patients with dysthyroid optic neuropathy (DON) after urgent orbital decompression. METHODS: This retrospective, observational case series study investigated 44 patients who exhibited several preoperative clinical factors that might be associated with the need for urgent orbital decompression due to DON. Additionally, the visual acuity of DON patients was compared between the patients preoperatively and at 1 and 6 months postoperatively. RESULTS: All 44 patients received steroid and with or without radiation therapy, with 27 patients able to avoid undergoing urgent surgery. However, the remaining 17 patients required urgent orbital decompression following a lack of response to the therapy. None of the patients who initially avoided surgery required additional surgery for DON. Factors significantly associated with the need for urgent orbital decompression surgery included: female gender, older age, long disease duration, unilateral significant DON, history of resistance to pulsed steroid therapy, unstable thyroid function, high TRAb (Thyrotrophin receptor antibody)value, poor visual acuity, presence of central diplopia, and presence of corneal problems (P < 0.05 each). The results also showed that postoperative visual outcomes of surgery for DON were acceptable. CONCLUSION: This study revealed several preoperative clinical factors for DON that appear to be associated with the need for urgent orbital decompression surgery in Japanese patients.

    DOI: 10.1186/s12886-020-1314-8

    PubMed

  • Rapid Regression of Scleral Melting Associated with Tumor Necrosis Factor-alpha in a Case of Surgically Induced Necrotizing Scleritis Reviewed

    Misawa Norihiko, Tagami Mizuki, Sakai Atsushi, Kohno Takeya, Honda Shigeru

    CASE REPORTS IN OPHTHALMOLOGY   11 ( 2 )   418 - 422   2020( ISSN:1663-2699

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000509260

    PubMed

  • Expression, intracellular localization, and mutation of EGFR in conjunctival squamous cell carcinoma and the association with prognosis and treatment. Reviewed

    Atsushi Sakai, Mizuki Tagami, Anna Kakehashi, Atsuko Katsuyama-Yoshikawa, Norihiko Misawa, Hideki Wanibuchi, Atsushi Azumi, Shigeru Honda

    PloS one   15 ( 8 )   e0238120   2020

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    PURPOSE: Conjunctival squamous cell carcinoma (SCC) is primarily treated with surgical resection. SCC has various stages, and local recurrence is common. The purpose of this study was to determine molecular localization of epidermal growth factor receptor (EGFR) and the possibility of EGFR as a biomarker for the management of conjunctival SCC. METHODS: In this retrospective study, we performed immunohistochemistry to evaluate EGFR expression and localization in tumor cells, EGFR mutation-specific expression (E746-A750del and L858R), and human papillomavirus expression in a series of 29 conjunctival SCCs. RESULTS: All 29 tumors in our cohort were EGFR positive (100%). Twenty-one of 29 tumors (72%) showed focal EGFR staining, and seven (28%) showed diffuse EGFR staining. In addition, we calculated the percentages of the two most important mutations in EGFR (exon 19 746-A750del (8/29, 27.5%), exon 21 (L858R mutant (2/29, 6.8%)) in conjunctival SCCs. We observed that the translocation of EGFR from the membrane into the cytoplasm was related to clinical prognosis, as we detected correlations between EGFR cytoplasmic staining and final orbital exenteration and between decreased EGFR membrane staining and progression-free survival. CONCLUSIONS: EGFR is important in the pathology of ocular surface squamous neoplasia including SCC and is a prognostic factor. Increased understanding of EGFR mutations may have important implications for future treatment options.

    DOI: 10.1371/journal.pone.0238120

    PubMed

  • Correlation between visual acuity and human leukocyte antigen DRB1*04 in patients with Vogt-Koyanagi-Harada disease Reviewed

    Misawa Norihiko, Tagami Mizuki, Kohno Takeya, Honda Shigeru

    BMC OPHTHALMOLOGY   19 ( 1 )   214   2019.11

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12886-019-1227-6

    PubMed

  • Correlation between visual acuity and human leukocyte antigen DRB1*04 in patients with Vogt-Koyanagi-Harada disease. Reviewed

    Norihiko Misawa, Mizuki Tagami, Takeya Kohno, Shigeru Honda

    BMC ophthalmology   19 ( 1 )   214 - 214   2019.11

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    BACKGROUND: The common presence of human leukocyte antigen (HLA)-DRB1*04 in Vogt-Koyanagi-Harada (VKH) disease is well known. The aim of this study was to investigate the relationship between visual prognosis and HLA-DRB1*04 alleles during systemic corticosteroid therapy in patients with VKH disease. METHODS: This retrospective case series included 57 eyes from 29 consecutive patients with treatment-naïve VKH disease who received systemic corticosteroid therapy. Visual acuity, sex, refractive error, central retinal thickness (CRT), central choroidal thickness (CCT), and duration from onset to treatment were measured at initial and final visits. Mean values of parameters were compared with each visit. Genotyping was performed by polymerase chain reaction amplification with sequence-specific primer. RESULTS: Linear regression showed significant differences in logMAR best-corrected visual acuity between the three groups of homozygotes, heterozygotes, and normal subjects at baseline (p < 0.01), at 3 months after treatment (p < 0.01). There was no significant differences at 6 months after treatment (p = 0.257). No significant differences were detected between the three groups in age, sex, refractive error, CRT, CCT, or duration from onset to treatment. CONCLUSION: Alleles of HLA-DRB1*04 might affect visual prognosis and be related to early response after initiation of treatment in VKH disease.

    DOI: 10.1186/s12886-019-1227-6

    PubMed

  • 臨床報告 緊急ドレナージを要した前頭洞mucoceleの眼窩および頭蓋内進展の1例

    坂井 淳, 田上 瑞記, 横田 知衣子, 寺西 裕一, 本田 茂

    眼科   61 ( 8 )   875 - 878   2019.08( ISSN:00164488

  • 緊急ドレナージを要した前頭洞mucoceleの眼窩および頭蓋内進展の1例 Reviewed

    坂井 淳, 田上 瑞記, 横田 知衣子, 寺西 裕一, 本田 茂

    金原出版(株) 眼科   61 ( 8 )   875 - 878   2019.08( ISSN:0016-4488

     More details

    Publishing type:Research paper (scientific journal)  

    <文献概要>はじめに 前頭洞粘液嚢胞(frontal mucocele)は,緊急ドレナージを要する前頭洞鼻腔嚢胞のなかでは上顎洞に次いで多く,鼻前頭洞管の閉塞が起点となり発生する。今回,前頭洞粘液嚢胞が感染を契機に膿瘍化し,眼窩および頭蓋内進展をきたした症例を報告する。症例 37歳,男性。数日前より左眼瞼の腫脹と発赤があり,近医眼科において加療されるも改善なく,当院紹介となった。初診時の矯正視力は左0.6,左上眼瞼腫脹および強い開眼制限を認めた。触診上,3横指程度の弾性硬の腫瘤性病変を触知したため,眼窩腫瘍を疑い眼窩部CTを施行した。CTでは左前頭洞から周囲の骨破壊を伴う腫瘤性病変を認め,腫瘤により眼窩内進展をきたし,眼球偏位とともに,前頭骨は部分的に欠損し,頭蓋内進展も認めた。急速増大傾向があることから膿瘍化が疑われ,頭蓋内への穿破を危惧しドレナージ目的で眼窩膿瘍切開術を行った。術中嚢胞内から多量の排膿をみた。後日,耳鼻咽喉科で根治的な内視鏡下鼻副鼻腔手術を施行し,術後は再発なく経過している。結論 前頭洞mucoceleはしばしば眼球突出など眼科症状を契機に発見されることがある。今回の症例のように,急速に増大する場合は感染を併発していることがあり,特に頭蓋内進展を伴う場合は加療が遅れると致命的な結果をきたす。可能な限り,膿瘍減圧のため眼窩膿瘍切開を早急に行う必要があると考える。急速に増大する眼窩腫瘤性病変では副鼻腔嚢胞の併発感染を鑑別診断に入れる必要がある。

  • 緊急ドレナージを要した前頭洞mucoceleの眼窩および頭蓋内進展の1例

    坂井 淳, 田上 瑞記, 横田 知衣子, 寺西 裕一, 本田 茂

    眼科   61 ( 8 )   875 - 878   2019.08( ISSN:0016-4488

     More details

    <文献概要>はじめに 前頭洞粘液嚢胞(frontal mucocele)は,緊急ドレナージを要する前頭洞鼻腔嚢胞のなかでは上顎洞に次いで多く,鼻前頭洞管の閉塞が起点となり発生する。今回,前頭洞粘液嚢胞が感染を契機に膿瘍化し,眼窩および頭蓋内進展をきたした症例を報告する。症例 37歳,男性。数日前より左眼瞼の腫脹と発赤があり,近医眼科において加療されるも改善なく,当院紹介となった。初診時の矯正視力は左0.6,左上眼瞼腫脹および強い開眼制限を認めた。触診上,3横指程度の弾性硬の腫瘤性病変を触知したため,眼窩腫瘍を疑い眼窩部CTを施行した。CTでは左前頭洞から周囲の骨破壊を伴う腫瘤性病変を認め,腫瘤により眼窩内進展をきたし,眼球偏位とともに,前頭骨は部分的に欠損し,頭蓋内進展も認めた。急速増大傾向があることから膿瘍化が疑われ,頭蓋内への穿破を危惧しドレナージ目的で眼窩膿瘍切開術を行った。術中嚢胞内から多量の排膿をみた。後日,耳鼻咽喉科で根治的な内視鏡下鼻副鼻腔手術を施行し,術後は再発なく経過している。結論 前頭洞mucoceleはしばしば眼球突出など眼科症状を契機に発見されることがある。今回の症例のように,急速に増大する場合は感染を併発していることがあり,特に頭蓋内進展を伴う場合は加療が遅れると致命的な結果をきたす。可能な限り,膿瘍減圧のため眼窩膿瘍切開を早急に行う必要があると考える。急速に増大する眼窩腫瘤性病変では副鼻腔嚢胞の併発感染を鑑別診断に入れる必要がある。

  • Impaired Retinal Circulation during Axitinib Treatment for Metastatic Renal Cell Carcinoma Reviewed

    Masashi Kimura, Sentaro Kusuhara, Mizuki Tagami, Makoto Nakamura

    Case Reports in Ophthalmology   10 ( 1 )   5 - 10   2019.01( eISSN:1663-2699

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    © 2019 The Author(s). Purpose: Axitinib, an orally administered vascular endothelial growth factor receptors 1, 2, and 3 inhibitor, is widely used as the second-line treatment for metastatic renal cell carcinoma. We present a case of metastatic renal cell carcinoma who developed a novel ocular adverse event, impaired retinal circulation, during axitinib therapy. Methods: This is an observational case report. Results: A 57-year-old male who had been treated with axitinib for metastatic renal cell carcinoma for 2 years presented in August 2015. He complained of sudden-onset abnormal visual field in his right eye. His right eye exhibited multiple soft exudates on fundus photography and a significant fluorescein filling delay of the retinal vessels on fluorescein angiography. His best corrected visual acuity (BCVA) was 20/20 in the right eye, and a cecocentral scotoma was detected by Goldmann perimeter. As axitinib could have been responsible for impaired retinal circulation, axitinib was terminated and switched to temsirolimus. The soft exudates gradually subsided and the patients' symptoms got better, but his right BCVA dropped to 20/63 3 months after the end of axitinib treatment with worsening of his general condition. Conclusion: Clinicians should be aware of retinal circulatory disorder that can occur in patients under axitinib treatment.

    DOI: 10.1159/000496197

    PubMed

  • Impaired Retinal Circulation during Axitinib Treatment for Metastatic Renal Cell Carcinoma. Reviewed

    Kimura M, Kusuhara S, Tagami M, Nakamura M

    Case reports in ophthalmology   10 ( 1 )   5 - 10   2019.01

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000496197

    PubMed

  • Comparison of 25- and 27-Gauge Pars Plana Vitrectomy in Repairing Primary Rhegmatogenous Retinal Detachment. Reviewed

    Otsuka K, Imai H, Fujii A, Miki A, Tagami M, Azumi A, Nakamura M

    Journal of ophthalmology   2018   7643174   2018( ISSN:2090-004X

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1155/2018/7643174

    PubMed

  • アキシチニブ内服中に著しい網膜循環障害をきたした1例 Reviewed

    木村 将, 楠原 仙太郎, 田上 瑞記, 本田 茂, 中村 誠

    眼科臨床紀要会 眼科臨床紀要   10 ( 11 )   950 - 950   2017.11( ISSN:1882-5176

     More details

    Publishing type:Research paper (scientific journal)  

  • Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion. Reviewed

    Tagami M, Sai R, Fukuda M, Azumi A

    Clinical ophthalmology (Auckland, N.Z.)   11   403 - 408   2017( ISSN:1177-5467

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.2147/OPTH.S128651

    PubMed

  • An unusual case of congenital cytomegalovirus infection-related retinopathy. Reviewed

    Tagami M, Honda S, Morioka I, Iijima K, Yamada H, Nakamura M

    BMC ophthalmology   16   81   2016.06

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12886-016-0246-9

    PubMed

  • Cyclosporine-Associated Leukoencephalopathy in a Case of Sympathetic Ophthalmitis. Reviewed

    Tagami M, Azumi A

    Case reports in ophthalmology   7 ( 1 )   61 - 6   2016.01

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000443826

    PubMed

  • 巨大結節性後部強膜炎の1例 Reviewed

    安武 博樹, 大西 健, 田上 瑞記, 福田 昌秀, 田口 浩司, 安積 淳

    (株)医学書院 臨床眼科   69 ( 5 )   635 - 639   2015.05( ISSN:0370-5579

     More details

    Publishing type:Research paper (scientific journal)  

    目的:強力な治療で軽快した巨大結節性後部強膜炎の1症例の報告。症例:48歳女性が両眼の強膜炎で紹介受診した。2ヵ月前に両眼の虹彩炎と診断され,1ヵ月後に両眼の強膜炎が発症した。ステロイド薬の局所と全身投与で改善がなかった。所見:矯正視力は右0.3,左0.8で,両眼に前房の強いフレアと硝子体混濁があり,上方の強膜に充血した結節があった。MRIで上方後部の強膜に強い肥厚があり,巨大結節性後部強膜炎と診断した。当初は治療に抵抗した。メチルプレドニゾロンなどの副腎皮質ステロイド薬の大量投与に,コルヒチンとメトトレキサートを加え,2ヵ月後に病勢が鎮静化した。結論:巨大結節性後部強膜炎は眼内腫瘍に似た所見を呈することがある。本症例のような難治例では,強力な抗炎症薬と免疫抑制薬の全身と局所投与が奏効した。(著者抄録)

  • 巨大結節性後部強膜炎の1例

    安武 博樹, 大西 健, 田上 瑞記, 福田 昌秀, 田口 浩司, 安積 淳

    臨床眼科   69 ( 5 )   635 - 639   2015.05( ISSN:0370-5579

     More details

    目的:強力な治療で軽快した巨大結節性後部強膜炎の1症例の報告。症例:48歳女性が両眼の強膜炎で紹介受診した。2ヵ月前に両眼の虹彩炎と診断され,1ヵ月後に両眼の強膜炎が発症した。ステロイド薬の局所と全身投与で改善がなかった。所見:矯正視力は右0.3,左0.8で,両眼に前房の強いフレアと硝子体混濁があり,上方の強膜に充血した結節があった。MRIで上方後部の強膜に強い肥厚があり,巨大結節性後部強膜炎と診断した。当初は治療に抵抗した。メチルプレドニゾロンなどの副腎皮質ステロイド薬の大量投与に,コルヒチンとメトトレキサートを加え,2ヵ月後に病勢が鎮静化した。結論:巨大結節性後部強膜炎は眼内腫瘍に似た所見を呈することがある。本症例のような難治例では,強力な抗炎症薬と免疫抑制薬の全身と局所投与が奏効した。(著者抄録)

  • 広義滲出型加齢黄斑変性に対するアフリベルセプト硝子体内投与の短期治療成績 Reviewed

    藤井 彩加, 今井 尚徳, 別所 紘奈, 大西 健, 田上 瑞記, 近藤 仁美, 田口 浩司, 安積 淳

    (株)メディカル葵出版 あたらしい眼科   32 ( 3 )   439 - 443   2015.03( ISSN:0910-1810

     More details

    Publishing type:Research paper (scientific journal)  

    目的:未治療の加齢黄斑変性(AMD)に対するアフリベルセプト硝子体内投与(IVA)の短期効果を検討する。対象および方法:IVA導入後、6ヵ月間経過観察しえた未治療AMD34例36眼を対象とした。導入治療は1ヵ月おき計3回施行、維持期はフレキシブル用法にてIVA継続した。導入前、導入後6ヵ月時点での視力、光干渉断層計(OCT)での滲出病変の変化を検討した。導入治療終了後1ヵ月時点で滲出病変が残存するものを「反応不良例」とし、性別、年齢、導入前視力、導入前病変最大直径、病型との関連性を検討した。結果:症例内訳は男性19例、女性15例、年齢48〜91歳(中央値77歳)であった。病型分類は典型AMD15眼、ポリープ状脈絡膜血管症18眼、網膜内血管腫状増殖3眼であった。視力に有意な変化はなく(p=0.23)、滲出病変は有意に減少した。反応不良例は7眼(19.4%)で、いずれの検討項目も反応不良例との関連はなかった。結論:未治療AMDに対し、IVA導入は有効である。(著者抄録)

  • 広義滲出型加齢黄斑変性に対するアフリベルセプト硝子体内投与の短期治療成績

    藤井 彩加, 今井 尚徳, 別所 紘奈, 大西 健, 田上 瑞記, 近藤 仁美, 田口 浩司, 安積 淳

    あたらしい眼科   32 ( 3 )   439 - 443   2015.03( ISSN:0910-1810

     More details

    目的:未治療の加齢黄斑変性(AMD)に対するアフリベルセプト硝子体内投与(IVA)の短期効果を検討する。対象および方法:IVA導入後、6ヵ月間経過観察しえた未治療AMD34例36眼を対象とした。導入治療は1ヵ月おき計3回施行、維持期はフレキシブル用法にてIVA継続した。導入前、導入後6ヵ月時点での視力、光干渉断層計(OCT)での滲出病変の変化を検討した。導入治療終了後1ヵ月時点で滲出病変が残存するものを「反応不良例」とし、性別、年齢、導入前視力、導入前病変最大直径、病型との関連性を検討した。結果:症例内訳は男性19例、女性15例、年齢48~91歳(中央値77歳)であった。病型分類は典型AMD15眼、ポリープ状脈絡膜血管症18眼、網膜内血管腫状増殖3眼であった。視力に有意な変化はなく(p=0.23)、滲出病変は有意に減少した。反応不良例は7眼(19.4%)で、いずれの検討項目も反応不良例との関連はなかった。結論:未治療AMDに対し、IVA導入は有効である。(著者抄録)

  • Scleral buckling for primary rhegmatogenous retinal detachment using noncontact wide-angle viewing system with a cannula-based 25 G chandelier endoilluminator. Reviewed

    Imai H, Tagami M, Azumi A

    Clinical ophthalmology (Auckland, N.Z.)   9   2103 - 7   2015( ISSN:1177-5467

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.2147/OPTH.S91339

    PubMed

  • Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis). Reviewed

    Handa JT, Tagami M, Ebrahimi K, Leibundgut G, Janiak A, Witztum JL, Tsimikas S

    Transactions of the American Ophthalmological Society   113   T5   2015( ISSN:0065-9533

     More details

    Publishing type:Research paper (scientific journal)  

    PubMed

  • 急性帯状潜在性外側網膜症における網膜外側に対する自己抗体(Autologous antibodies to outer retina in acute zonal occult outer retinopathy) Reviewed

    Tagami Mizuki, Matsumiya Wataru, Imai Hisanori, Kusuhara Sentaro, Honda Shigeru, Azumi Atsushi

    シュプリンガー・ジャパン(株) Japanese Journal of Ophthalmology   58 ( 6 )   462 - 472   2014.11( ISSN:0021-5155

     More details

    Publishing type:Research paper (scientific journal)  

    急性帯状潜在性外側網膜症(AZOOR)患者5名(12〜65歳)を対象として、自己抗体の検出を試みた。視野検査、光学コヒーレンストモグラフィー(OCT)、多局所網膜電図(mfERG)を受けた患者の眼科的データを分析した。マウス網膜と患者の血清中の網膜自己抗体を免疫組織化学的に検討した。3成績では霧視、2成績では視野欠損が見られた。全例が視野検査でマリオット盲点の肥大を示した。暗点に対応する部位のOCT所見は、内側および外側線分間の接合部縁の破壊を示した。対応する暗点部分では、mfERG振幅が減少した。マウス網膜の全光受容体で、標的抗原が観察され、ヒト血清でも候補抗原が検出された。全患者で抗網膜抗原が検出され、AZOORは自己免疫病であると考えられた。

  • Autologous antibodies to outer retina in acute zonal occult outer retinopathy. Reviewed

    Tagami M, Matsumiya W, Imai H, Kusuhara S, Honda S, Azumi A

    Japanese journal of ophthalmology   58 ( 6 )   462 - 72   2014.11( ISSN:0021-5155

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10384-014-0347-z

    PubMed

  • 急性帯状潜在性外側網膜症における網膜外側に対する自己抗体(Autologous antibodies to outer retina in acute zonal occult outer retinopathy)

    Tagami Mizuki, Matsumiya Wataru, Imai Hisanori, Kusuhara Sentaro, Honda Shigeru, Azumi Atsushi

    Japanese Journal of Ophthalmology   58 ( 6 )   462 - 472   2014.11( ISSN:0021-5155

     More details

    急性帯状潜在性外側網膜症(AZOOR)患者5名(12~65歳)を対象として、自己抗体の検出を試みた。視野検査、光学コヒーレンストモグラフィー(OCT)、多局所網膜電図(mfERG)を受けた患者の眼科的データを分析した。マウス網膜と患者の血清中の網膜自己抗体を免疫組織化学的に検討した。3成績では霧視、2成績では視野欠損が見られた。全例が視野検査でマリオット盲点の肥大を示した。暗点に対応する部位のOCT所見は、内側および外側線分間の接合部縁の破壊を示した。対応する暗点部分では、mfERG振幅が減少した。マウス網膜の全光受容体で、標的抗原が観察され、ヒト血清でも候補抗原が検出された。全患者で抗網膜抗原が検出され、AZOORは自己免疫病であると考えられた。

  • 広義滲出型加齢黄斑変性へのラニビズマブ硝子体内投与反応不良例に対するアフリベルセプト硝子体内投与の短期成績 Reviewed

    金井 美智子, 今井 尚徳, 藤井 彩加, 大西 健, 田上 瑞記, 近藤 仁美, 田口 浩司, 安積 淳

    (株)医学書院 臨床眼科   68 ( 6 )   825 - 829   2014.06( ISSN:0370-5579

     More details

    Publishing type:Research paper (scientific journal)  

    目的:ラニビズマブ硝子体内投与(IVR)反応不良であった滲出型加齢黄斑変性(AMD)に対するアフリベルセプト硝子体内投与(IVA)の短期効果を検討する。方法:IVR導入期に反応不良であり,その後も再治療に抵抗した症例に対しIVA導入し6ヵ月以上経過観察したAMD12例12眼を対象とした。男性10例,女性2例で,年齢は68〜86歳,中央値75歳であった。病型内訳は典型AMD 6眼,ポリープ状脈絡膜血管症6眼であった。IVA導入前後の視力と病変の変化を検討した。結果:IVA導入前後で比較すると,視力は維持され(p=0.402),漿液性網膜剥離離,網膜色素上皮剥離は有意に減少したが(p=0.002,p=0.013),網膜内浮腫は有意な変化はなかったp=0.219)。結論:IVR導入期反応不良例であったAMDに対し,IVAは有効であった。(著者抄録)

  • 広義滲出型加齢黄斑変性へのラニビズマブ硝子体内投与反応不良例に対するアフリベルセプト硝子体内投与の短期成績

    金井 美智子, 今井 尚徳, 藤井 彩加, 大西 健, 田上 瑞記, 近藤 仁美, 田口 浩司, 安積 淳

    臨床眼科   68 ( 6 )   825 - 829   2014.06( ISSN:0370-5579

     More details

    目的:ラニビズマブ硝子体内投与(IVR)反応不良であった滲出型加齢黄斑変性(AMD)に対するアフリベルセプト硝子体内投与(IVA)の短期効果を検討する。方法:IVR導入期に反応不良であり,その後も再治療に抵抗した症例に対しIVA導入し6ヵ月以上経過観察したAMD12例12眼を対象とした。男性10例,女性2例で,年齢は68~86歳,中央値75歳であった。病型内訳は典型AMD 6眼,ポリープ状脈絡膜血管症6眼であった。IVA導入前後の視力と病変の変化を検討した。結果:IVA導入前後で比較すると,視力は維持され(p=0.402),漿液性網膜剥離離,網膜色素上皮剥離は有意に減少したが(p=0.002,p=0.013),網膜内浮腫は有意な変化はなかったp=0.219)。結論:IVR導入期反応不良例であったAMDに対し,IVAは有効であった。(著者抄録)

  • Topical Treatment for Orbital Capillary Hemangioma in an Adult Using a β-Blocker Solution. Reviewed

    Ohnishi K, Tagami M, Morii E, Azumi A

    Case reports in ophthalmology   5 ( 1 )   60 - 5   2014.01

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000360392

    PubMed

  • Forskolin modifies retinal vascular development in Mrp4-knockout mice. Reviewed

    Matsumiya W, Kusuhara S, Hayashibe K, Maruyama K, Kusuhara H, Tagami M, Schuetz JD, Negi A

    Investigative ophthalmology & visual science   53 ( 13 )   8029 - 35   2012.12( ISSN:0146-0404

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1167/iovs.12-10781

    PubMed

  • Uveal extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type with concomitant extraocular lesions in a Japanese man. Reviewed

    Tagami M, Nagai T, Sekimukai D, Hara R, Azumi A

    Japanese journal of ophthalmology   55 ( 5 )   585 - 587   2011.09( ISSN:0021-5155

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10384-011-0013-7

    PubMed

  • ポッター症候群の表現型を伴うpapillorenal症候群の生存例(A surviving case of papillorenal syndrome with the phenotype of Potter sequence) Reviewed

    Fujioka Kazumichi, Morioka Ichiro, Nozu Kandai, Nishimoto Masashi, Amano Mariko, Tagami Mizuki, Honda Shigeru, Yokoyama Naoki, Yamada Hideto, Iijima Kazumoto, Matsuo Masafumi

    John Wiley & Sons Australia, Ltd Pediatrics International   53 ( 3 )   406 - 408   2011.06( ISSN:1328-8067

     More details

    Publishing type:Research paper (scientific journal)  

    腹膜透析を含む心肺集中治療により命を取り留めた、ポッター症候群を伴うpapillorenal症候群患者の1症例について検討した。母親は35歳で、前置胎盤と羊水過少のため妊娠27週で周産期センターに移送された。MRI検査にて腎臓無形成および肺低形成の胎児を認め、極めて予後不良な典型的ポッター症候群と診断した。37週5日目に帝王切開を実施し、児の体重は2410g、1、5分時のアプガースコアはそれぞれ3、6であった。出生直後に気管挿管し、新生児ICUに収容後、人工換気とprostaglandin I2、強心剤の投与を行った。経皮的酸素飽和度(SpO2)は90%未満であった。出生2日目に左肺気胸が発現したため、持続的胸腔ドレナージを行った。薬剤を増量したところ、A-a DO2は次第に減少した。4日齢で腹膜透析(PD)を開始し、5日齢のSpO2は100%に達した。両側腎低形成および視神経異常からpapillorenal症候群と診断した。男児は3ヵ月齢時、体重3425gで自動PDは継続のうえで退院した。

  • A surviving case of papillorenal syndrome with the phenotype of Potter sequence. Reviewed

    Fujioka K, Morioka I, Nozu K, Nishimoto M, Amano M, Tagami M, Honda S, Yokoyama N, Yamada H, Iijima K, Matsuo M

    Pediatrics international : official journal of the Japan Pediatric Society   53 ( 3 )   406 - 8   2011.06( ISSN:1328-8067

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1442-200X.2010.03261.x

    PubMed

  • ポッター症候群の表現型を伴うpapillorenal症候群の生存例(A surviving case of papillorenal syndrome with the phenotype of Potter sequence)

    Fujioka Kazumichi, Morioka Ichiro, Nozu Kandai, Nishimoto Masashi, Amano Mariko, Tagami Mizuki, Honda Shigeru, Yokoyama Naoki, Yamada Hideto, Iijima Kazumoto, Matsuo Masafumi

    Pediatrics International   53 ( 3 )   406 - 408   2011.06( ISSN:1328-8067

     More details

    腹膜透析を含む心肺集中治療により命を取り留めた、ポッター症候群を伴うpapillorenal症候群患者の1症例について検討した。母親は35歳で、前置胎盤と羊水過少のため妊娠27週で周産期センターに移送された。MRI検査にて腎臓無形成および肺低形成の胎児を認め、極めて予後不良な典型的ポッター症候群と診断した。37週5日目に帝王切開を実施し、児の体重は2410g、1、5分時のアプガースコアはそれぞれ3、6であった。出生直後に気管挿管し、新生児ICUに収容後、人工換気とprostaglandin I2、強心剤の投与を行った。経皮的酸素飽和度(SpO2)は90%未満であった。出生2日目に左肺気胸が発現したため、持続的胸腔ドレナージを行った。薬剤を増量したところ、A-a DO2は次第に減少した。4日齢で腹膜透析(PD)を開始し、5日齢のSpO2は100%に達した。両側腎低形成および視神経異常からpapillorenal症候群と診断した。男児は3ヵ月齢時、体重3425gで自動PDは継続のうえで退院した。

  • Impact of intravitreal injection of tissue plasminogen activator on full-field electroretinogram in patients with macular oedema secondary to retinal vein occlusion. Reviewed

    Tagami M, Kusuhara S, Imai H, Honda S, Tsukahara Y, Negi A

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde   226 ( 2 )   81 - 6   2011( ISSN:0030-3755

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000326242

    PubMed

  • Bilateral Optic Disc Anomalies Associated with PAX2 Mutation in a Case of Potter Sequence. Reviewed

    Tagami M, Honda S, Morioka I, Matsuo M, Negi A

    Case reports in ophthalmology   1 ( 2 )   94 - 98   2010.11

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000321625

    PubMed

  • MRP4 knockdown enhances migration, suppresses apoptosis, and produces aggregated morphology in human retinal vascular endothelial cells. Reviewed

    Tagami M, Kusuhara S, Imai H, Uemura A, Honda S, Tsukahara Y, Negi A

    Biochemical and biophysical research communications   400 ( 4 )   593 - 8   2010.10( ISSN:0006-291X

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bbrc.2010.08.109

    PubMed

  • Knockdown of Multidrug Resistance-Associated Protein 4 by Sima Enhances Cell Migration and Tube Formation in Human Retinal Endothelial Cells Reviewed

    Tagami M, Kusuhara S, Imai H, Honda S, Tsukahara Y, Negi A

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE   51 ( 13 )   2010.04( ISSN:0146-0404

     More details

    Publishing type:Research paper (scientific journal)  

  • Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy. Reviewed

    Tagami M, Kusuhara S, Honda S, Tsukahara Y, Negi A

    Brain research   1283   186 - 93   2009.08( ISSN:0006-8993

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.brainres.2009.05.095

    PubMed

  • Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab. Reviewed

    Tagami M, Kusuhara S, Honda S, Tsukahara Y, Negi A

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie   246 ( 12 )   1787 - 9   2008.12( ISSN:0721-832X

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00417-008-0949-6

    PubMed

▼display all

MISC

  • 眼球突出の鑑別 眼球突出に対する体系的な診断アプローチ 臨床所見,画像診断,人種差の考慮

    田上 瑞記

    眼科   67 ( 9 )   809 - 813   2025.09( ISSN:0016-4488

     More details

    <文献概要>眼球突出(exophthalmosまたはproptosis)は,眼球が眼窩から前方に押し出された状態を指し,多くの眼科・全身性疾患の初発症状として出現する。臨床的には,Hertel眼球突出計での測定値が18mm以上,または左右差が2~3mm以上の場合に異常とみなされるのが一般的である。しかし,正常範囲の判断には年齢・性別・人種といった背景因子を考慮する必要があり,個々のベースラインとの差異が重要である。

  • A Case of Choroidal Mucosa-associated Lymphoid Tissue (MALT) Lymphoma in which Rituximab Monotherapy Resulted in Improvement in Visual Acuity and Long-term Remission

    三澤宣彦, 田上瑞記, 春名優甫, 冨田真未, 坂井淳, 田中さやか, 康秀男, 康秀男, 本田茂

    日本眼科学会雑誌   129 ( 4 )   2025( ISSN:0029-0203

     More details

  • ディープラーニングを用いた甲状腺眼症の評価プログラム開発:Mambaの有効性の検証

    黒崎涼, 西尾瑞穂, 春名優甫, 木成玄, 冨田真未, 田上瑞記, 本田茂, 村垣善浩

    日本生体医工学会大会プログラム・抄録集(Web)   64th   2025

     More details

  • メトトレキサート休薬により急速に消退した眼窩 医原性免疫不全関連リンパ増殖異常症の1例

    田上瑞記, 木成玄, 本田茂, 赤羽裕太, 孝橋賢一

    九州眼科学会プログラム・講演抄録集   95th   2025

     More details

  • 眼トキソプラズマ症による黄斑部網膜動脈閉塞の1例

    木成玄, 田上瑞記, 坂井淳, 三澤宣彦, 冨田真未, 春名優甫, 本田茂

    眼科臨床紀要   18 ( 4 )   2025( ISSN:1882-5176

     More details

  • 眼炎症疾患患者の続発緑内障における視神経乳頭周囲網膜神経線維層厚の変化

    坂井淳, 田上瑞記, 春名優甫, 冨田真未, 三澤宣彦, 本田茂

    眼科臨床紀要   18 ( 4 )   2025( ISSN:1882-5176

     More details

  • 硝子体手術(PVD作成とILM peeling)へ

    田上瑞記

    眼科手術   38   2025( ISSN:0914-6806

     More details

  • 【眼腫瘍 症例検討会~日常診療で眼腫瘍を見落とさないために~】(1章)もしや眼腫瘍? 診断のポイント 眼窩の腫瘍

    田上 瑞記

    眼科グラフィック   13 ( 5 )   568 - 573   2024.10( ISSN:2187-2422

  • 【眼部悪性腫瘍の診断と治療】眼付属器リンパ腫 MALTリンパ腫とDLBCLを中心に

    田上 瑞記

    眼科   66 ( 10 )   969 - 975   2024.10( ISSN:0016-4488

     More details

    <文献概要>眼付属器リンパ腫とは主に眼窩内(涙腺を含む)に発生するリンパ腫の総称である。

  • 炎症・感染とこれからの眼科診療 眼炎症を克服するための精密医療の実現に向けて

    楠原 仙太郎, 松宮 亘, 吉川 敦子, 淺原 俊一郎, 木戸 良明, 小川 渉, 西庄 龍東, 曽谷 尭之, 岸 真椰, 橘 吉寿, 内匠 透, 金 景佑, 村井 佑輔, 荒井 美奈, 坂本 麻里, 盛 崇太朗, 牧 仁美, 今井 尚徳, 田上 瑞記, 園田 康平, 蕪城 俊克, 柳井 亮二, 丸山 和一, 金子 優, 篠原 正和, 浅井 義之, 中津井 雅彦, 早野 崇英, 柏木 賢治, 中村 誠

    日本眼科学会雑誌   128 ( 3 )   234 - 255   2024.03( ISSN:0029-0203

     More details

    精密医療とは臨床情報・遺伝情報・環境因子を含む多くのデータセットから患者を層別化し,それぞれのグループに最適な治療法や予防法を提供するものである.ぶどう膜炎診療では,ぶどう膜炎の病期,眼炎症の活動性とその程度,眼炎症が眼組織に及ぼす影響などを考慮しながら,目の前のぶどう膜炎患者に最適な治療を適宜選択する必要がある.このアプローチ法は精密医療そのものであるが,現状の検査法と治療法から得られるデータセットは質・量ともに十分とはいえない.この問題を解決するために我々は,従来とは異なる検査情報の取得,新規治療法の開発,大規模データベースの構築に取り組んできた.1.眼炎症の「見える化」を目指した生体イメージングの開発古くからぶどう膜炎における炎症評価方法のゴールドスタンダードは検眼鏡所見である.ぶどう膜炎では検眼鏡的に炎症所見が軽微であっても網膜組織障害が慢性に進行する場合があり,そのような症例では治療の匙加減に悩むことがしばしばある.我々は光干渉断層計(OCT)を活用することによって,硝子体細胞の特徴がぶどう膜炎の分類に有用であることを見出し,en face slab OCT imagingによりぶどう膜炎に伴う網膜内層障害を二次元的に評価することに成功した.さらに,二光子顕微鏡によるマウス網膜のin vivo imagingでは,炎症惹起に伴うミクログリアの動的な反応を評価できることを明らかにした.ヒト生体網膜での炎症細胞の動的な可視化は現実的ではないが,マウス網膜で得られた知見を適切な生体プローブの動態に関連づけることによって,構造異常が認められない段階での網膜細胞異常の有無を臨床で可視化できるようになると思われる.これらの生体イメージングによる眼炎症の「見える化」は,眼炎症と網膜組織障害の詳細な評価を介して,きめ細やかな眼炎症管理に貢献するものと期待される.2.ぶどう膜炎続発緑内障の克服を目指した新しい濾過手術近年の生物学的製剤の登場と硝子体手術の低侵襲化によって,ぶどう膜炎における主要な失明原因は黄斑病変から続発緑内障へとシフトしていくことが予想される.ぶどう膜炎続発緑内障は原発開放隅角緑内障に比べ高眼圧であり視野障害の進行が速いことから,原発開放隅角緑内障とは異なる治療戦略で長期的な視機能維持を目指す必要がある.我々は,ぶどう膜炎続発緑内障ではRho-associated coiled-coil forming kinase(ROCK)阻害薬点眼が著効する症例が存在すること,谷戸フックを用いた線維柱帯切開術(眼内法)の治療成績が原発開放隅角緑内障と遜色がないことを明らかにした.一方,濾過手術の進化はぶどう膜炎続発緑内障の管理に必須である.著者が発明したTenon開創器は術中にTenon嚢-強膜間のスペースを確保することによって結膜への影響を最小限にマイトマイシンCの効果を得ることを目的としたデバイスである.これに独特な強膜フラップ処理と独自の結膜縫合法を組み合わせることによって,濾過胞管理の不要な新しい線維柱帯切除術が誕生した.また,我々が行ったロングチューブシャント手術の改良もぶどう膜炎続発緑内障に対する低侵襲濾過手術の実現に貢献している.ぶどう膜炎続発緑内障に対するこれらの治療法の登場によって,ぶどう膜炎患者の視機能が長期的に維持されることを期待したい.3.自己免疫網膜症に対する精密医療への取り組み自己免疫網膜症は網膜細胞を標的とする自己免疫反応が亜急性に網膜視細胞を不可逆的に障害するまれな疾患である.自己免疫網膜症の診断については抗網膜自己抗体の特異度が低いこと,治療に関しては標準化された治療アルゴリズムがないことがそれぞれ問題となっている.また,視機能が不可逆的に障害される前に治療効果を判定できる他覚的な疾患バイオマーカーがないことも自己免疫網膜症診療を難しくしている主因となっている.そこで我々は,日本眼炎症学会とJapan Ocular Imaging Registryの助力を得て,自己免疫網膜症患者の大規模臨床データベースの作成,患者血液を用いた網羅的プロテインアレイによる主要な抗網膜抗体の決定,患者血液を用いた代謝物データと臨床データの統合解析による臨床バイオマーカーの探索を目指した多機関研究を行うこととした.本研究で得られる質の高いデータセットを活用することによって,自己免疫網膜症の精密医療が進むものと考えている.(著者抄録)

  • 増殖糖尿病網膜症の術後VHとOCT angiographyの術前評価の相関

    春名優甫, 坂井淳, 木成玄, 冨田真未, 田上瑞記, 本田茂

    日本網膜硝子体学会総会プログラム・講演抄録集   63rd (CD-ROM)   2024

     More details

  • 甲状腺眼症の消炎治療と眼圧変動

    田上瑞記, 春名優甫, 冨田真未, 浅野和男, 安積淳, 本田茂

    日本眼窩疾患シンポジウムプログラム・抄録集   38th   2024

     More details

  • 眼トキソプラズマ症による黄斑部網膜動脈閉塞の1例

    木成玄, 田上瑞記, 坂井淳, 三澤宣彦, 冨田真未, 春名優甫, 本田茂

    日本眼感染症学会・日本眼炎症学会・日本コンタクトレンズ学会総会・日本涙道・涙液学会プログラム・講演抄録集   60th-57th-7th   2024

     More details

  • 眼炎症疾患患者の続発緑内障における視神経乳頭周囲網膜神経線維層厚の変化

    坂井淳, 田上瑞記, 春名優甫, 冨田真未, 三澤宣彦, 本田茂

    日本眼感染症学会・日本眼炎症学会・日本コンタクトレンズ学会総会・日本涙道・涙液学会プログラム・講演抄録集   60th-57th-7th   2024

     More details

  • A case of aggressive natural killer cell leukemia with orbital mass

    春名優甫, 田上瑞記, 木成玄, 冨田真未, 坂井淳, 田中さやか, 本田茂

    日本眼腫瘍学会誌   13   2024( ISSN:2187-3178

     More details

  • 眼腫瘍症例検討会~日常診療で眼腫瘍を見落とさないために~1章 もしや眼腫瘍?診断のポイント〈3〉眼窩の腫瘍

    田上瑞記

    眼科グラフィック   13 ( 5 )   2024( ISSN:2187-2422

     More details

  • -Ocular adnexa lymphoma: MALT and DLBCL etc.-

    田上瑞記

    眼科   66 ( 10 )   2024( ISSN:0016-4488

     More details

  • 脈絡膜MALTリンパ腫に対しリツキシマブ単剤投与にて視力改善と長期寛解を得た1例

    三澤宣彦, 田上瑞記, 春名優甫, 冨田真未, 坂井淳, 本田茂

    眼科臨床紀要   17 ( 9 )   2024( ISSN:1882-5176

     More details

  • ステロイドパルス療法における副作用についての検討

    春名優甫, 田上瑞記, 木成玄, 冨田真未, 坂井淳, 三澤宣彦, 本田茂

    日本眼感染症学会・日本眼炎症学会・日本コンタクトレンズ学会総会・日本涙道・涙液学会プログラム・講演抄録集   60th-57th-7th   2024

     More details

  • 【再考!網膜剥離手術】シャンデリア照明と広角観察システムを併用した網膜復位術

    田上 瑞記

    眼科手術   36 ( 2 )   205 - 210   2023.04( ISSN:0914-6806

     More details

    網膜復位術(バックリング手術)は硝子体手術の劇的な進歩もあり,適応症例は減少しているが,今でも絶対的適応の症例は存在し,網膜硝子体術者としては必ず習得すべき術式である.一方で,広角観察システムを中心とした手術機器の進歩は,その術式選択に大きな変遷をもたらしつつある.本稿では,シャンデリア照明と広角観察システムを併用した方法について,その由来,詳細な実際の手技・ポイント,本術式を選択する利点・欠点,さらには今後の展望などを自験および参考文献の内容をもとに概説する.(著者抄録)

  • Author Correction: Discovery of widespread transcription initiation at microsatellites predictable by sequence-based deep neural network (Nature Communications, (2021), 12, 1, (3297), 10.1038/s41467-021-23143-7)

    Grapotte M.

    Nature Communications   13 ( 1 )   2022.12

     More details

  • 左結膜に限局性の微小形質転換びまん性大細胞型B細胞リンパ腫(Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva)

    Harada Naonori, Tagami Mizuki, Koh Hideo, Ohsawa Masahiko, Hino Masayuki, Nakamae Hirohisa

    International Journal of Hematology   114 ( 4 )   413 - 414   2021.10( ISSN:0925-5710

  • A case of frontal mucocele needed emergency orbital drainage due to intracranial invasion Reviewed

    坂井 淳, 田上 瑞記, 横田 知衣子, 寺西 裕一, 本田 茂

    金原出版, 眼科   61 ( 8 )   875 - 878   2019.08( ISSN:0016-4488

     More details

    Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

    CiNii Research

  • A case of frontal mucocele needed emergency orbital drainage due to intracranial invasion

    坂井 淳, 田上 瑞記, 横田 知衣子, 寺西 裕一, 本田 茂

    眼科   61 ( 8 )   875 - 878   2019.08( ISSN:0016-4488

     More details

  • A case of giant nodular posterior scleritis Reviewed

    安武 博樹, 大西 健, 田上 瑞記

    医学書院, 臨床眼科   69 ( 5 )   635 - 639   2015.05( ISSN:0370-5579

     More details

    Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

    DOI: 10.11477/mf.1410211324

    CiNii Research

  • 日本人男性における眼球外病変を合併した粘膜関連リンパ系組織型のブドウ膜節外性辺縁帯B細胞リンパ腫(Uveal extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type with concomitant extraocular lesions in a Japanese man) Reviewed

    Tagami Mizuki, Nagai Takayuki, Sekimukai Daisuke, Hara Rumiko, Azumi Atsushi

    シュプリンガー・ジャパン(株) Japanese Journal of Ophthalmology   55 ( 5 )   585 - 587   2011.09( ISSN:0021-5155

     More details

    Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

  • 日本人男性における眼球外病変を合併した粘膜関連リンパ系組織型のブドウ膜節外性辺縁帯B細胞リンパ腫(Uveal extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type with concomitant extraocular lesions in a Japanese man)

    Tagami Mizuki, Nagai Takayuki, Sekimukai Daisuke, Hara Rumiko, Azumi Atsushi

    Japanese Journal of Ophthalmology   55 ( 5 )   585 - 587   2011.09( ISSN:0021-5155

  • 【患者さんも納得・安心 レーザー治療はこわくない!】どう答える?レーザー治療に対する患者さんからの質問10 レーザー治療以外の方法はないのですか? Reviewed

    田上 瑞記

    (株)メディカ出版 眼科ケア   12 ( 12 )   1230 - 1231   2010.12( ISSN:1344-8293

     More details

    Publishing type:Article, review, commentary, editorial, etc. (scientific journal)   Kind of work:Single Work  

  • 【患者さんも納得・安心 レーザー治療はこわくない!】どう答える?レーザー治療に対する患者さんからの質問10 レーザー治療後、日常生活で気を付けることはありますか? Reviewed

    田上 瑞記

    (株)メディカ出版 眼科ケア   12 ( 12 )   1232 - 1232   2010.12( ISSN:1344-8293

     More details

    Publishing type:Article, review, commentary, editorial, etc. (scientific journal)   Kind of work:Single Work  

  • 【患者さんも納得・安心 レーザー治療はこわくない!】どう答える?レーザー治療に対する患者さんからの質問10 レーザー治療後、日常生活で気を付けることはありますか?

    田上 瑞記

    眼科ケア   12 ( 12 )   1232 - 1232   2010.12( ISSN:1344-8293

  • 【患者さんも納得・安心 レーザー治療はこわくない!】どう答える?レーザー治療に対する患者さんからの質問10 レーザー治療以外の方法はないのですか?

    田上 瑞記

    眼科ケア   12 ( 12 )   1230 - 1231   2010.12( ISSN:1344-8293

▼display all

Presentations

▼display all

Grant-in-Aid for Scientific Research

  • Is the development of orbital disease related to T cell immune exhaustion and aging?

    Grant-in-Aid for Scientific Research(C)  2025

  • Is the development of orbital disease related to T cell immune exhaustion and aging?

    Grant-in-Aid for Scientific Research(C)  2024

Charge of on-campus class subject

  • 臨床医科学(視覚病態学)

    2025   Intensive lecture   Graduate school

  • 臨床医科学演習(視覚病態学)

    2025   Intensive lecture   Graduate school

  • 視覚病態学(制御学特論)

    2025   Intensive lecture   Graduate school

  • 視覚病態学(病態学特論)

    2025   Intensive lecture   Graduate school

  • 視覚病態学演習

    2025   Intensive lecture   Graduate school

Charge of off-campus class subject

  • 眼科学

    Institution:Kobe University

  • 眼科学

    Institution:Osaka City University